Common fragile sites. Structure, replication and their role in chromosome instabiity by Bosco, Nazario
   
 
 
 
SAPIENZA 
Università di Roma  
Facoltà di Scienze Matematiche Fisiche e Naturali 
 
 
DOTTORATO DI RICERCA  
IN GENETICA E BIOLOGIA MOLECOLARE 
 
XXIII Ciclo  
(A.A. 2009/2010) 
 
 
 
Common fragile sites: structure, replication  
and their role in chromosome instability 
 
 
 
Dottorando 
Nazario Bosco 
 
 
 
 
Docente guida  
Prof. Franca Pelliccia 
 
 
Tutor 
Prof. Francesca Degrassi Coordinatore  
 Prof. Irene Bozzoni 
   
 
 
   
 
 
 
TABLE OF CONTENT 
 
 
 
 
ABSTRACT 1 
  
  
INTRODUCTION 3 
1. Fragile sites 3 
2. Common fragile sites 8 
3. Replication pattern at common fragile sites 10 
4. Common Fragile sites and cancer 13 
5. DNA damage checkpoints regulate common fragile site 
stability 
 
17 
6. Mechanism of common fragile site instability: a working 
model for fragile site expression 
 
22 
  
  
DAPI INDUCIBLE FRAGILE SITES 27 
  
  
AIM OF THE RESEARCH 33 
  
  
RESULTS AND DISCUSSION 37 
PART 1. Molecular characterization of the human common 
fragile site FRA7B 
 
37 
PART 2.  Replication timing of two human common fragile 
sites: FRA1H and FRA2G 
 
48 
PART 3. Fragility and genome instability 55 
  
   
CONCLUSIONS 75 
  
  
MATERIAL AND METHODS 79 
1. Human lymphocytes primary cultures 79 
2. Cell lines 79 
3. Spreads preparation 80 
4. Probes and in situ hybridization 80 
4.1. Cellular culture of E. coli and DNA extraction 80 
4.2. Telomeric probe 82 
4.3. Nick Translation 82 
4.4. Fluorescent in situ hybridization 82 
4.5. Detection of probes 83 
5. BrdU labelling 83 
6. Sequence analysis of fragile regions 83 
  
  
REFERENCES 85 
  
  
ACKNOWLEDGEMENTS 103 
 
 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 1  
 
 
 
 
ABSTRACT 
 
 
 
 Common fragile sites (CFS) are specific regions of 
mammalian chromosomes that are particularly prone to 
gaps/breaks. The analysis of these sequences has not definitively 
clarified the causes of their fragility. There is evidence that CFSs 
are regions of late/slowed replication in the presence of 
sequence elements that have the propensity to form secondary 
structures, and that the cytogenetic expression of CFSs may be 
due to unreplicated DNA. They are a cause of genome 
instability, and the location of many CFS correlates with many 
breakpoints of aberrations recurrent in some cancers.  
 In the first part of this work the DNA sequence of the 
CFS FRA7B was determined, and then analyzed to identify 
structural features potentially involved in fragility. FRA7B maps 
at the 7p chromosome terminal region and is one of the largest 
CFS analyzed so far. A 90kb-long sequence that presents very 
high DNA helix flexibility values was identified. This sequence 
could have a role in inducing stalling of the replication fork and 
fragility at FRA7B (Bosco et al., 2010). 
 In order to analyze the relationship between DNA 
replication time and fragility, I have also investigated the 
replication timing of sequences mapping within two CFSs 
(FRA1H and FRA2G). Our results indicate that the fragile 
sequences are slow replicating. Thus these regions could 
sometimes reach mitosis unreplicated and be expressed as 
chromosome gaps/breakages (Pelliccia et al., 2008). 
 The last part focused on the role of common fragile sites 
in the generation of genome instability seen in cancer. Common 
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fragile sites FRA1H, FRA2G and the later characterized 
FRA7B, are known to be frequent breakpoints in chromosome 
aberrations in various neoplasms. A panel of 21 human cancer 
cell lines was analyzed for the presence of deletions or genome 
amplification mediated by these CFSs. The results revealed the 
presence of a duplicated region on a chromosome der(2) present 
in the karyotype of two analyzed leukemia cell lines K562, 
K562-1 and K562-2. The two duplicated regions have different 
lengths and are organized into two large palindromes, which 
suggests that one BFB cycle has occurred. The localization of 
the breakpoints were molecularly defined, and are localized in 
the sequence of three common fragile sites: FRA2H, which was 
molecularly characterized in this work, the newly identified 
aphidicolin inducible fragile site FRA2S, and FRA2G (Pelliccia 
et al., 2010).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 3  
 
 
 
 
INTRODUCTION 
 
 
 
1. Fragile sites 
 
 The first description of non-random human chromosome 
fragility was reported in 1965 in cells from a woman previously 
irradiated (Dekaban, 1965).  
The term ‘fragile site’ was later introduced by Hecht to 
describe recurrent chromosome breaks on the long arm of 
chromosome 16, which segregated in a Mendelian fashion in a 
large family and showed linkage to the haptoglobin locus 
(Magenis et al., 1970).  
Since that time, fragile sites continued as an active area 
of research in cytogenetics and their definition and classification 
were subject to several controversies with the increasing of 
knowledge.  
 Today fragile sites are defined as specific loci that 
preferentially exhibit gaps and breaks on metaphase 
chromosomes following partial inhibition of DNA synthesis. 
Fragile sites are normally stable in cultured cells, but 
form visible gaps and breaks under certain conditions or 
treatment with specific chemical compounds (Fig. 1).  
To date, according to the Genome Database and to a 
recent global genome screening, more than 200 different fragile 
sites have been identified in the human genome (Mrasek et al., 
2010). 
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Figure 1. Giemsa stained metaphase obtained from human lymphocyte. The 
arrowhead shows fragile sites expression. 
 
 
 
 
To date, a chromosome specific nomenclature has been 
proposed for fragile sites. Each fragile site name starts with the 
abbreviation FRA followed by the chromosome number and a 
capital letter according to the appearance of the fragile site 
description from the short to the long arm of the chromosome, 
starting from A to Z, e.g. FRA1A was the first fragile site 
described on chromosome 1 in 1p36.  
The study of fragile sites has had a major impact on 
human genetics, most notably in leading to the identification of 
the fragile X syndrome and trinucleotide repeat expansion as a 
mutational mechanism in human genetic disease. Fragile sites 
have also been associated with genome instability in cancer cells 
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and with activation of DNA damage response to stalled 
replication. 
Fragile sites are generally categorized into two main 
classes based on their population frequency and pattern of 
inheritance. Each class is further subdivided according to their 
specific mode of induction in vitro, i.e. their culture 
requirements (Sutherland and Hecht, 1985; Tab. 1). 
‘Rare fragile sites’ are present in less than 5% of the 
population, segregate in a Mendelian manner (Sutherland, 
2003), and increased breakage at these sites is most often caused 
by expansion of nucleotide repeats. The major group of rare 
fragile sites is the folate-sensitive group associated with CGG-
repeat expansion. This group includes FRAXA, in the FMR1 
gene, which is responsible for the fragile X syndrome, and 
FRAXE in the FMR2 gene, which is associated with non 
specific mental retardation (Yu et al., 1991; Gu et al., 1996). 
Other nonfolate-sensitive rare fragile sites, characterized by 
expanded AT-rich minisatellite repeats, are induced by 
bromodeoxyuridine (BrdU) or distamycin A. These include 
FRA10B and FRA16B, in which alleles with greatly expanded 
42- and 33-AT minisatellite repeats are expressed as fragile sites 
(Hewett et al., 1998; Yu et al., 1997, Tab.1). 
‘Common fragile sites’, which are seen in all 
individuals, are the largest class of fragile sites. Unlike rare 
fragile sites, common fragile sites represent a component of 
normal chromosome structure and are not the result of mutated 
nucleotide repeat expansion. The cytogenetic expression of these 
sites varies from individual to individual, reaching a level of 
expression up to 30% in some (Sutherland and Richards, 1995). 
Gaps and breaks are visible over wide chromosomal regions of 
megababses in size. Common fragile sites seem therefore to 
represent regions of fragility, rather then specific loci as seen for 
rare fragile sites in which the breakage corresponds to the 
expanded locus (Handt et al., 2000). Their study has its roots in 
the early investigations of the fragile X syndrome when 
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recurrent, site-specific chromosome breaks were noted in cells 
from both normal and affected individuals when grown under 
conditions of folate stress used to induce the cytogenetic 
expression of the fragile X site FRAXA. It was later determined 
that the great majority of common fragile sites are also 
specifically and reproducibly induced by low doses of 
aphidicolin, an inhibitor of DNA polymerases (Glover et al., 
1984). Sites of recurrent chromosome breakage on normal 
chromosomes following treatment of cells with BrdU or 5-
azacytidine have also been described and considered as common 
fragile sites (Sutherland et al., 1985; Tab. 1). 
An interesting feature of common fragile sites is their 
evolutionary conservation among all mammalian species 
examined to date, e.g. primates, horse, cow, pig, dog, cat, rat, 
deer, mouse (Ruiz-Herrera et al., 2006, and references cited 
therein). The fact that common fragile sites persist in widespread 
phyla suggests they serve for a conserved, to date not 
understood, important biological role.   
 Thus, the understanding of the mechanism and the 
molecular basis of fragile sites is highly important for the 
comprehension and management of a series of biological 
processes and human pathologies.   
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2. Common fragile sites 
 
 In cultured cells, common fragile sites are hotspots for 
metaphase chromosome gaps/breaks and induced chromosomes 
rearrangements. After induction, common fragile sites are 
regions of potential genome instability (Glover, 1998), being 
hotspots for deletion and translocations (Glover and Stein, 1988; 
Wang et al., 1997), increased rates of sister chromatid exchange 
(Glover and Stein, 1987; Feichtinger and Schmid, 1989; Hirsch, 
1991), plasmid or viral integration (Rassool FV et al., 1991; 
Wilke et al., 1996; Mishmar et al., 1998) and intrachromosomal 
gene amplification (Coquelle et al., 1997; Hellman et al., 2002; 
Debatisse et al., 1998). Based on these characteristics and the 
association with cancer breakpoints on banded chromosomes, a 
number of early reports suggested that common fragile sites 
could be responsible for some of the chromosome 
rearrangements observed in cancer (Hecht and Glover, 1984; 
Yunis and Soreng, 1984).  
 At present more then twenty common fragile sites have 
been cloned and characterized at the molecular level in various 
ways (Mrasek et al., 2010). The genomic breakage and 
instability at these sites occur along a large genomic region 
extending over at least 500 kb (Paradee et al., 1996). All are 
relatively AT-rich areas (Boldog et al., 1997), but they do not 
show any repeat motifs such as expanded trinucleotide or 
minisatellite repeats that could predispose to fragility as has 
been demonstrated in the rare fragile sites (Arlt et al., 2002; 
Mishmar et al., 1998; Paradee et al., 1994). To understand the 
molecular mechanism of fragility at these sites, another 
investigative approach was adopted in which structural 
characteristics of the DNA rather than their sequence per se was 
examined. 
 When measuring local fluctuations at the twist angle 
between consecutive base pairs along the DNA molecule 
backbone, it was found that many of the common fragile site 
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regions analyzed to date, contain more areas of high DNA 
torsional flexibility, termed flexibility peaks, than non-fragile 
regions mapped to the same chromosome band (Arlt et al., 2002; 
Schwartz et al., 2006; Fig. 2A). These flexibility peaks, which 
can be present as ‘cluster of flexibility peaks’ when including at 
least three close-set peaks (Zlotorynski et al., 2003), are 
composed of interrupted AT-dinucleotide-rich sequences of 
various length termed AT-dinucleotide-rich flexibility islands. 
These islands, which are significantly more AT-dinucleotide-
rich than their nonflexible flanking sequences, have the potential 
to form unusual DNA secondary structures that can perturb 
replication (Zlotorynski et al., 2003; Fig. 2).  
 
 
Figure 2. A. Schematic representation of the twist angle of DNA helix. 
B. Example of predicted secondary structure by Mfold program of an 
AT-dinucleotide rich flexibility island (taken from Zlotorynski et al., 
2003). 
 
 
The AT-rich flexible regions contained in the common 
fragile sites are similar to the AT-minisatellite repeat of the 
FRA16B and FRA10B rare fragile sites. These sequences have 
the potential to form secondary structures able to affect DNA 
replication (Zlotorynski et al., 2003). Moreover, the FRA16B 
AT minisatellite exclude nucleosomes affecting the chromatin 
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structure (Hsu and Wang, 2002). Thus, the molecular basis of 
rare and common fragile sites may actually be the same or very 
similar. However the molecular mechanism underlying the 
genetic instability at fragile site remains to be investigated. 
 
 
3. Replication pattern at common fragile sites 
 
 The two conditions that induce expression of the 
majority of human fragile sites, folate deprivation and 
aphidicolin, both inhibit DNA replication, leading to the idea 
that either stalled or collapsed replication forks or unreplicated 
DNA that persists into metaphases is the cause of fragile site 
expression.  
Supporting the idea that fork stalling is important, 2D gel 
analysis of expanded CGG/GCC repeat sequences analyzed in 
both E. coli and yeast cells directly demonstrated stalled or 
slowed replication forks that mapped to the repeated sequence 
(Samadashwily et al., 1997; Pelletier et al., 2003). Recent data 
from Freudenreich’s lab, have shown that a short sequence that 
includes the high flexibility peaks within the common fragile 
site FRA16D, stalls a replication fork when replicated on a 
plasmid in yeast cells (Zhang and Freudenreich, 2007). The AT 
repeats embedded in the FRA16D flexible region are predicted 
to easily form either an hairpin (from a single-strand of DNA) or 
cruciform (from double-stranded DNA) structure (Zhang and 
Freudenreich, 2007). In addition the flexible sequence 
significantly increases chromosome breakage, which is further 
enhanced by either the presence of replication inhibitors or 
absence of the DNA repair protein Rad52. 
 Replication timing of fragile sites was first evaluated at 
the rare FRAXA site (Hansen et al., 1993). It was found that the 
normal allele of the FRAXA region replicates in late S phase, 
while replication of alleles with CGG expansions was delayed 
until G2/M. Interestingly, the region of replication delay was 
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quite large, 400 kb or more on either side of the repeat 
expansion, suggesting that more than a single stalled fork is 
involved (Subramanian et al., 1996). The AT minisatellite 
expansion at FRA10B and FRA16B also result in a replication 
delay, although the region of delay for FRA10B mapped 
somewhat distal to the repeat expansion (Handt et al., 2000).  
 Common fragile sites FRA3B and FRA16D are also both 
late replicating, and for FRA3B exposure to aphidicolin delays 
replication further, resulting in a failure to complete replication 
in some cells (Le Beau et al., 1998; Palakodeti et al., 2004). 
FRA3B replication timing studies in different cell lines showed 
that the replication of this site is asynchronous, one allele 
replicate later than the other, with or without aphidicolin 
treatment, and that fragility was preferentially observed on the 
late replicating allele (Wang et al., 1999). This result suggests a 
possible relationship between particular alleles and fragility. 
Common fragile site FRA7H has a more complicated pattern of 
replication with allelic asynchrony that is further enhanced by 
aphidicolin (Hellman et al., 2000). This latter pattern is 
consistent with a stochastic inhibition or slowing of replication, 
such as would happen at a sequence with a potential to stall a 
fork. 
 Furthermore, mammalian chromosomes present two 
distinct genome domains: G-bands and R-bands. G-bands are 
regions with high A/T content, replicate late in S-phase, are 
relatively insensitive to DNase I, are gene poor and rich in LINE 
elements. Complementary R-bands, instead, are G/C rich, 
replicate early in S-phase, are DNase sensitive, are rich in gene 
and Alu elements (Gardiner, 1995). Takebayashi et al. (2001) 
showed that replication forks typically slow down during the 
early-mid S-phase, when R/G transition occurs. In a later work 
from the same lab, was shown that the replication timing 
switches precisely from early to late S phase, when the 
replication forks proceed through the putative R/G chromosomal 
band boundary predicted by marked changes in GC content, at a 
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sequence level, of the region 1q31.3 (R-band)-1q32.1 (G-band) 
(Takebayashi et al., 2005). These data suggest that the 
slowdown of replication is a general feature of R/G band 
boundaries existing throughout the genome. Common fragile 
sites usually map at band boundaries. Moreover, some common 
fragile sites mapping to R-bands share structural features with 
the chromatin of G-bands, simulating a G/R band boundary 
(Mishmar et al., 1999). This different chromatin organization of 
common fragile sites might affect the replication and 
condensation of the fragile sequences and thus contribute to the 
fragility. 
 There could also be a link between replication origins 
and fragile sites, as peaks of high flexibility are over-represented 
at mapped mammalian replication origins. Furthermore, FISH 
analysis of aphidicolin-treated hamster cells revealed fragile site 
expression at two origins (Toledo et al., 2000). The same group 
has also shown that nucleotide pool levels can modify origin 
usage, so that a pattern of one dominant origin can switch to a 
pattern of many weaker origins during condition of replication 
stress (Anglana et al., 2003). Thus, either a change in origin 
usage or more persistent origin bubbles could create areas of 
increased susceptibility to breakage. For example, one might 
imagine that if a previously inactive high flexibility sequence 
became an active origin in the presence of aphidicolin, it could 
give opportunity for formation of a secondary structure that 
would preclude normal replication and become a fragile site 
(Freudenreich, 2007).  
Furthermore, in general AT islands are hypervariable 
elements due to polymerase slippage during replication and/or 
unequal recombination events (Bois and Jeffreys, 1999). The 
flexibility, thermodynamic instability and propensity to form 
superhelical duplexes of AT-rich regions are consistent with the 
idea that AT islands may serve as anchorage sites for DNA on 
the nuclear matrix (Matrix Attachment Regions, MARs) 
(Woynarowski et al., 2001). It’s known that MARs are regions 
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prone to unwinding and bending, contain topoisomerase II 
binding and cleavage sites and possibly can acts as DNA 
replication origins. Thus these regions may constitute hot spots 
for breakage and DNA recombination and may be involved in 
chromosome fragility (Svetlova et al., 2001). 
 
 
4. Common fragile site and cancer 
 
 Numerous studies have shown that common fragile sites 
are frequently involved in chromosome breakages and 
rearrangements in cancer cells. The fragile site-specific 
rearrangement most frequently observed is one or more large 
deletions of ten to hundreds of kilobases directly within the 
fragile region, resulting in inactivation of associated genes.  
Most studies have focused on FRA3B and FRA16D, 
because they are the two most frequently expressed and best-
characterized common fragile sites, and both lie within the large 
tumor suppressor genes, FHIT and WWOX, respectively. 
 The FHIT (fragile histidine triad) gene catalyzes 
hydrolysis of diadenosine polyphosphates, produced via action 
of the aminoacyl-tRNA synthetases, and is the major 
diadenosine triphosphate (ApppA) hydrolase found in mammals 
(Barnes et al., 1996). Its function has been linked to intracellular 
signaling and the DNA damage response (Pekarsky et al., 2004; 
Shi et al., 2000). There is ample evidence that FHITp acts as a 
tumor suppressor. Fhit-deficient mice have increased 
susceptibility to N-nitrosomethylbenzylamine (NMBA)-induced 
gastric tumors, which can be rescued by introduction of a 
functional Fhit allele (Zanesi et al., 2001). In addition, 
overexpression of FHIT suppresses growth of different cancer 
cell lines both in vitro and in vivo (Siprashvili et al., 1997). 
FHIT is frequently involved in biallelic loss and other 
chromosome abnormalities in tumors (Huebner and Croce, 
2003; Ohta et al., 1996). FHIT deletions, abnormal transcripts, 
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promoter hypermethylation, and associated loss of expression 
are common in human malignancies. In cancer cells, these 
events are often associated with deletions directly within the 
FRA3B region, centering on exon 5 of FHIT.  
 Recent results from Aqeilan et al. (2007) and others 
(Bednarek et al., 2001; Paige et al., 2001) also demonstrate a 
tumor suppressor function for the WWOX gene. WWOX encodes 
a 46-kDa protein that contains two WW domains, a compact 38 
amino acid residue units that fold into a three-stranded β-sheet 
structure, and a short-chain dehydrogenase/reductase domain 
that may function in apoptotic pathways (Chang, 2002; Chang et 
al., 2001, 2003). Deletions of microsatellite markers within the 
FRA16D/WWOX locus are prevalent in several tumor types 
including breast, prostate, esophageal, lung, stomach, and 
pancreatic carcinomas (Durkin and Glover, 2007).  
Furthermore, similar deletion patterns in cancer cells 
have also been shown for other common fragile sites and 
associated genes (Tab. 2). Thus, a considerable amount of data 
show that many common fragile sites represent targets that are 
‘weak links’ for genomic alterations in at least some cancer cells 
(Huebner and Croce, 2001). 
Furthermore, recent findings suggest that both common 
and rare fragile sites contain a number of microRNA (Calin et 
al, 2004). Over half of the mapped microRNA lies in known 
fragile chromosome regions. The high level of evolutionary 
conservation observed at common fragile sites might be the 
result of important regulatory sequences found there that include 
miRNA genes, which can be encoded in both intronic and 
intergenic regions. Interestingly, many characterized common 
fragile sites lie inside very large genes. 
While deletion breakpoints within common fragile sites 
in cancer cells are common, relatively fewer translocations 
involving fragile sites have been reported. Translocation 
involving FRA3B have been found in a small number of tumor 
cell lines, including hepatocellular, esophageal, and breast 
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carcinoma (Fang et al., 2001; Keck et al., 1999; Popovici et al., 
2002). On the contrary, FRA16D is a site of frequent 
translocations in multiple myelomas. As many as 25% of all 
multiple myelomas contain a recurrent translocation between 
16q23 and 14q32, resulting in at least one truncated allele of 
WWOX in these tumor cells (Chesi et al., 1998). Translocations 
have also been reported at several others common fragile sites, 
including FRA6E and FRA6F in acute lymphoblastic and acute 
myeloid leukemia, and FRA2G in members of a family with 
multifocal clear renal cell carcinoma (Sinclair et al., 2005). The 
relatively low numbers of reported translocations versus 
deletions may simply reflect the processes of biological 
selection in tumor cells. Both deletions and translocations at 
common fragile sites appear simply to inactivate associated 
genes rather than deregulate their expression or create fusion 
genes with altered functions. As such, there may not be any 
difference in selective advantage conveyed by these two types of 
chromosomal rearrangements. 
 
 
Table 2. Genes and murine orthologs associated with cloned Common 
Fragile Sites (from Durkin and Glover, 2007). 
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In addition to deletion and translocation breakpoints, 
common fragile sites have been associated to viral integration 
and gene amplification in tumor cells. The FRA3B region was 
also found to contain human cervical cancer HPV-16 integration 
sites (Wilke et al., 1996), which led to findings of additional 
viral integration sites at common fragile sites in tumors or tumor 
cell lines (Popescu and DiPaolo, 1989; Smith et al., 1992; 
Thorland et al., 2000). 
 Gene amplification, that is the increase of copy number 
of a definite chromosome region, is a genome alteration 
observed in many human neoplasms that produce overdosage of 
oncogenes mapped in the amplified regions. The identification 
and analysis of these regions therefore often allow the discovery 
of new putative oncogenes. 
 The amplified sequences can be present both in the 
continuity of a chromosome as ‘homogeneous staining regions’ 
(HSR), and as small free chromatin structures known as ‘double 
minutes’ (DM). The mechanisms underlying these 
manifestations of genome instability are under investigation. In 
particular, there is some evidence that common fragile sites can 
initiate breakage-fusion-bridge (BFB) cycles, a mechanism 
responsible for accumulation of intrachromosomal (HSR) 
amplicons (Coquelle et al., 1997; Kuo et al., 1994; Fig. 3). More 
recently, FRA7I and FRA7G have been identified at one 
boundary of the amplicons found in two tumor-derived cell lines 
(Hellmann et al., 2002). 
 In the model of intrachromosomal gene amplification 
obtained by break at common fragile sites, the amplicons appear 
to be arranged in head-to-head organized ladders obtained by 
BFB events (McClintok, 1951, Fig. 3). Two common fragile 
sites may set boundaries of the early amplicon: the break at the 
more telomeric site determining the telomeric loss and then the 
sister chromatid fusion, and the break at the more centromeric 
site defining the amplicon size (Coquelle et al., 1997 and 
references cited therein). BFB cycle repetition is probably 
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interrupted when the amplified chromosome is stabilized by the 
addition of a telomere. Cytogenetic analyses have demonstrated 
the validity of this model in rodents (Coquelle et al., 1997; Kuo 
et al., 1994), and in human cancer (Shuster et al., 2000; Ciullo et 
al., 2002; Hellmann et al., 2002; Zimonjic et al., 2003; Reshmi 
et al., 2007). 
 
5. DNA damage checkpoints regulate common fragile site 
stability 
 
 Little was known of the cellular mechanisms controlling 
common fragile site stability until it was discovered that the 
Ataxia-telengiectasia and Rad3 Related (ATR) checkpoint 
kinase plays a major role in regulating fragile site stability 
(Casper et al., 2002). During S and G2 phases of the cell cycle, 
when DNA is replicated and chromosomes prepared for mitosis, 
the ATM (Ataxia Telengiectasia Mutated) and ATR kinases act 
in parallel, as a major DNA damage checkpoint proteins in 
overlapping pathways (Harrison and Haber, 2006). ATM 
responds primarily to DNA double strand breaks, while ATR 
orchestrates the signaling of downstream effector molecules that 
respond to stalled and collapsed replication forks. Cells lacking 
functional ATR are deficient in checkpoint responses to UV 
light and agents that block replication fork progression, 
including hydroxyurea, aphidicolin and hypoxia conditions 
(Nghiem et al., 2001). 
Based on the appearance of chromosome gaps and breaks at 
common fragile sites following replication stress and the 
mechanism of action of agents that induce cytogenetic fragile 
site expression, Casper and colleagues (2002) studied the effects 
of ATM and ATR deficiency of these proteins on common 
fragile site breakages. ATR, but not ATM, was found to play a 
major role in maintaining the stability of common fragile sites, 
by directing the cellular checkpoint response to stalled 
replication at these sites. 
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Cells lacking ATR, in fact, showed a dramatic increase 
in fragile site expression following treatment with low doses of 
aphidicolin. Furthermore, ATR deficiency alone, without 
addition of replication inhibitors, induced a low frequency of 
spontaneous gap and breaks at common fragile sites, showing 
that ATR is required for common fragile site stability even 
during unperturbed replication, and indicating that some level of 
replication stalling occurs normally at fragile site regions. 
 In contrast, ATM-deficient cells did not exhibit 
spontaneous or aphidicolin-induced common fragile site breaks. 
This lack of increased breakage in ATM-deficient cells suggest 
that double strand breaks are not the initial or primary cause of 
cytogenetic common fragile site expression. However, the ATM 
pathway may be important in regulating subsequent event at 
common fragile sites, particularly in the resolution of double 
strand breaks that must occur in these regions to give rise to 
chromosomal rearrangements. 
 Casper et al. (2004) subsequently found that cells from 
individuals from Seckel syndrome, which contain a 
hypomorphic mutation in ATR, show dose-responsive increased 
breakage at common fragile sites.  
 The discovery that ATR is intimately involved in 
regulating the stability of common fragile sites was important to 
linking cell cycle checkpoint function to fragile site stability. 
Subsequent investigation have focused on further 
delineation of these mechanisms, and a number of targets or 
modifiers of the ATR-regulated pathway have now been shown 
to influence common fragile site stability, including BRCA1, 
CHK1, the Fanconi Anemia (FA) pathway proteins, and the 
SMC1 (Arlt et al., 2004; Durkin et al., 2006; Howlett et al., 
2005; Musio et al., 2005). 
 Howlett et al. (2005) examined the role of the Fanconi 
Anemia pathway in regulation of common fragile site stability. 
The FANCD2 protein is activated via mono-ubiquitination 
during S-phase, signaling its translocation to BRCA1- and 
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RAD51-positive nuclear foci (Taniguchi and D’Andrea, 2002). 
It had also been shown that ATR phosphorylates FANCD2 and 
is required for its efficient mono-ubiquitination (Andreassen et 
al., 2004). These results suggested a role for the FA pathway in 
the response to DNA replication stress and so, in the 
maintenance of common fragile site stability. More recently, 
Hickson’s group showed, that replication inhibitors such as 
aphidicolin induce sister chromatid DNA bridges as replication 
intermediates, specifically at common fragile site loci. These 
structures, marked by FANCD2/FANCI foci, inefficiently 
resolved before anaphase by DNA repair protein complexes, will 
lead to anaphase bridges, then to chromosome breakages, and so 
forth, to all events derived from these breakages (Chan et al., 
2009). 
It has been suggested that breaks at common fragile sites 
may serve as a ‘signature’ of stalled or delayed replication in 
tumor cells, aggravated by deficiencies in the S-phase and G2/M 
checkpoints or associated repair genes during tumorigenesis 
(Casper et al., 2002). Concomitant with these events was a high 
frequency of LOH at known common fragile regions, including 
FRA3B. These findings suggest that in precancerous lesion, 
replication stress leads to stalled or collapsed replication forks, 
resulting in the activation of the ATR- and, with subsequent 
DNA double strand breaks, the ATM-dependent checkpoints. 
Cells that do not undergo apoptosis or cell cycle arrest will 
develop deletions and allelic imbalances that could preferentially 
target common fragile sites, since they are most sensitive to 
replication stress (Durkin and Glover, 2007). Further mutations 
in p53 or other genes will release additional checkpoint 
restrictions and lead to tumor progression. These findings 
suggest that lesions at common fragile sites are indicators of 
replication stress during early stages of tumorigenesis and might 
explain why deletions within fragile sites are so frequent in 
cancer cells.  
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Given the high frequency of instability at common 
fragile sites and associated sensitivity to replication stress, the 
question has often arisen whether fragile site-mediated 
inactivation of associated genes in cancer cells support a 
functional role for these genes in cancer progression or simply 
represent a ‘bystander effect’ of fragile site instability. As more 
and more common fragile site are characterized at the molecular 
level, it appears that many are associated with deletions and 
rearrangement in different tumor cells. There is ample evidence 
to support a tumor suppressor function of genes such as FHIT 
and WWOX. However, deletions of genes with no obvious role 
in tumor progression, such as steroid sulfatase (STS), found at 
FRAXA, have also been observed in tumor cells (Arlt et al., 
2002). Thus, both answers to this question may be correct, in 
that lesions at common fragile sites can serve as ‘signature’ of 
replication stress during tumorigenesis, and some associated 
genes, can confer a selective growth advantage to cells in which 
they are deleted. 
Based on the appearance of deletions and chromosome 
rearrangements in cultured and tumor cells, double strand breaks 
can clearly occur at common fragile sites, either directly or as a 
consequence of the misrepair of stalled replication forks. 
Homologous Recombination Repair (HRR) plays a major role in 
responding to double strand breaks and stalled or collapsed 
replication forks during S and G2, when the sister chromatids 
are present. It has been hypothesized that SCEs (Sister 
Chromatid Exchanges) are formed by the action of HRR during 
replication. Glover and Stein (1987) reported that, on average 
70% of all gaps and breaks at FRA3B after aphidicolin treatment 
had a SCE at that site, suggesting a role for HRR in the repair of 
lesion at common fragile sites. Furthermore, aphidicolin-induced 
replication stress leads to RAD51 focus formation and 
phosphorylated DNA-PKcs, key components of the HRR and 
NHEJ (Non-Homologous End-Joining) double strand breaks 
repair pathways, respectively (Schwartz et al., 2005). The 
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downregulation of RAD51, DNA-PKcs, or LIGIV, an additional 
component of the NHEJ repair pathway, leads to a significant 
increase in replication stress-induced common fragile site 
expression in MCF7 cells. Replication stress also resulted in 
formation of foci of double strand break markers, MDC1 and 
γH2AX, which colocalized with those of RAD51 and phospho-
DNA-PKcs (Schwartz et al., 2005). These findings support the 
idea that double strand breaks are formed at common fragile 
sites as a result of replication perturbation and provide the first 
clues into how lesions are repaired at common fragile sites. 
Additional mechanistic studies will undoubtedly provide greater 
detail of the exact nature of the lesions at common fragile sites 
and their repair. 
 
 
6. Mechanism of common fragile site instability: a working 
model for fragile site expression 
 
The identification of CGG trinucleotide repeat expansion 
as the molecular basis for the appearance of the rare fragile sites, 
e.g. FRAXA in the FMR1 gene, suggested early on that common 
fragile site breakage might have a related mechanism. However, 
unlike rare fragile sites, no expanded di- or trinucleotide repeat 
sequences have been identified within common fragile sites. 
Nonetheless, sequences, and perhaps repetitive elements, could 
still be important factors affecting common fragile sites 
instability. 
Common fragile sites contain a relatively high AT-rich 
sequence including long stretches of perfect AT microsatellite 
sequence, or AT-islands with high DNA flexibility, at least in 
some analysed common fragile sites. Zlotorynski et al. (2003) 
have shown that the sequences at flexibility peaks are composed 
of interrupted runs of AT-dinucleotides, and these sequences 
show similarity to the AT-rich minisatellite repeats that underlie 
the fragility of the rare fragile sites FRA16B and FRA10B. Such 
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sequences have the potential to form secondary structures and, 
hence, may affect replication at fragile sites. 
 If common fragile sites require specific sequences for 
their ‘fragility’, then large deletions that remove the necessary 
sequences should cause the affected common fragile sites to lose 
their ‘fragility’. Arlt et al. (2002) found that two tumor cell lines 
containing a 500 kb deletion of FRAXB completely eliminated 
fragility at this site. However on contrary, Corbin et al. (2002) 
examined FRA3B in hybrid cells containing tumor-derived 
chromosomes 3 with large FRA3B intralocus deletions and 
found that the deletions did not reduce aphidicolin-induced 
fragility. In a recent intensive study of somatic cell hybrids 
containing large 200-600 kb deletions of FRA3B that deleted 
several major flexibility peaks, fragility of this site was 
significantly reduced but not absent (Durkin and Glover, 2007). 
These results suggest that loss of large blocks of sequences 
within common fragile sites reduces, but does not result in 
complete loss of fragility and that common fragile site 
expression on metaphase chromosomes likely reflects the effects 
of a number of sequences across the large fragile region.  
Ragland et al. (2008) showed that integration of 
sequences from FRA3B are sufficient to recapitulate fragile site-
like instability at a novel genomic location. Cell clones 
containing stable integrated FRA3B sequences at unique 
nonfragile site loci retained fragile site-like instability at ectopic 
sites. However they found that the fragility of integrated 
common fragile site sequences was not dependent on late 
replication.  
These data suggest that for common fragile sites there 
must not be only a single feature that makes these sequences 
‘fragile’, but further analyses are required to study in depth the 
mechanisms that make fragile sites ‘fragile’. 
Summarizing what has been said so far, based on 
aphidicolin-mediated inhibition of DNA polymerase, Glover et 
al. (1984) proposed, in the initial descriptions of common fragile 
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sites, that breakage was caused by preferential inhibition of 
DNA replication at these sites. Since then, numerous lines of 
evidence continue to support this basic hypothesis. The 
underlying molecular basis for stalled replication following 
replication stress is not entirely understood but likely relates to 
sequence and late replication at fragile sites. To date, data from a 
number of laboratories support a working model for common 
fragile sites expression. This model is based on late or delayed 
replication, unusual sequence composition, and the role of 
checkpoint and repair proteins in fragile site stability (Fig. 4). It 
suggests that the AT-rich sequences at common fragile sites, 
present difficulties during replication that are further 
exacerbated by aphidicolin and certain other forms of replication 
stress. When cells are treated with low dose of aphidicolin, the 
polymerase slow or pause, likely leaving the helicase/topoI 
complex to continue unwinding DNA ahead of it, and resulting 
in long stretches of ssDNA that can activate the ATR-dependent 
DNA damage checkpoint. These ssDNA regions may form 
secondary structures, such as hairpins or cruciforms at the AT-
repeats, which can further perturb replication as the polymerases 
encounter them. Although the majority of these perturbations are 
likely detected by ATR damage checkpoint and DNA repair 
machinery, some escape and present themselves as gaps and 
breaks on metaphase chromosomes, particularly at common 
fragile sites. 
This model is also supported by the observation that 
treatment of cells with low doses of camptothecin, an inhibitor 
of topoisomerase I, can almost completely prevent the breaks at 
common fragile sites induced by aphidicolin (Arlt and Glover, 
2010). These results suggest that polymerase-helicase 
uncoupling may be an initial key event in common fragile site 
instability after replication perturbation and provide new insight 
into early conditions required for fragile site breakage.  
Recently Le Beau has proposed that a unique epigenetic 
pattern may underlie the unusual sensitivity of common fragile 
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sites to replication interference (Jiang et al., 2009). They 
analyzed chromatin modification patterns within the six human 
common fragile sites with the highest levels of breakage, and 
their surrounding non fragile regions. Chromatin at most of the 
common fragile sites analyzed has significantly less histone 
acetylation than the control non fragile regions. Moreover, 
Trichostatin A and/or 5-azadeoxycytidine treatments reduced 
chromosome breakage at common fragile sites. These data show 
that histone hypoacetylation is a characteristic epigenetic pattern 
of common fragile sites, and suggest that chromatin at common 
fragile sites might be relatively more compact, underlying a role 
for chromatin conformation in fragile site expression. 
Furthermore, lack of histone acetylation at common fragile sites 
may contribute to the defective response to replication stress 
observed in these regions. 
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DAPI INDUCIBLE FRAGILE SITES 
 
 
 
 
DAPI (4’-6-diamidino-2-phenilindole) is a non-
intercalating fluorescent compound that binds specifically to AT 
bases of double-stranded DNA in the minor groove (Fig. 5). 
Footprinting experiments show that a sequence of (AT)n>4 is 
covered when DAPI is bound (Jeppesen and Nielsen, 1989; 
Portugal and Waring, 1988). When DAPI molecules are bound 
contiguously to AT-rich areas, the DNA conformation is 
changed, favoring further compound binding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. A model for DAPI (4’-6-Diamidino-2-Phenilindole) 
DNA binding in minor groove, and its molecular structure. 
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On human chromosomes, DAPI inhibits the complete 
spiralization of some well-defined chromosomal areas 
(Matsukuma and Utakoji, 1978). DAPI can also act as an 
undercondensing agent when supplied to cells after DNA 
synthesis, during G2 phase (Prantera et al., 1981). When human 
lymphocytes are grown in complete media, this compound 
induces a sub-normal condensation of the heterochromatic areas 
of chromosomes 1, 9, 16 and Yq, as well as four gaps and breaks 
on chromosomes 1q, 2q, 7p and 13q (Pelliccia and Rocchi, 
1986). After chromosome banding, these gaps/breaks were 
mapped at specific chromosomal bands and have been identified 
as common fragile sites induced by different treatments: 
FRA1H, at 1q41-42, induced by 5-azacytidine (Sutherland et al., 
1985); and the three aphidicolin inducible common fragile sites 
FRA2G, at 2q24-31, FRA7B at the terminal region of the short 
arm of chromosome 7, FRA13C, at 13q21-22 (Glover et al., 
1984; Yunis and Soreng, 1984). This group of fragile sites could 
be considered as a new DAPI-inducible class (Fig. 6). 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The DAPI-inducible common fragile site family.  
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Rocchi and Pelliccia (1988) suggest that the large 
heterochromatic areas and the four common fragile sites induced 
by DAPI consist of late replicating areas that possess DAPI-
specific binding sequences. The combination of late replication 
(as an intrinsic characteristic of common fragile sites) with the 
presence of sequences receptive to DAPI, make this 
uncondensed region available for further DAPI binding and thus 
no longer capable of undergoing normal condensation.  This 
hypothesis is in agreement with what happens in the 
heterochromatic areas, in which the frequency of 
subcondensation induced by DAPI is very high. These areas are, 
in fact, very AT-rich and late replicating. In conditions that 
further delay their replication (such as thymidylate stress, e.g. 
growth in 199 medium) their sensitivity to DAPI is highly 
increased. 
 FRA1H, spanning about 10 Mb, maps at the distal part 
of the G-band 1q41 and at the proximal part of the R-band 
1q42.1, thus lying on the boundary of bands with different 
replication timing in S-phase (Curatolo et al., 2007, Fig. 7). 
FRA1H is the first characterized common fragile site whose 
expression is not induced by aphidicolin but instead by DAPI 
and 5-azacytidine. The analysis of the fragile region with the 
FlexStab program showed the presence of an AT-rich 120 kb 
long region that has a very large number of flexibility peaks. 
This sequence is located at the beginning of the most fragile 
FRA1H region and, because of its potential to form secondary 
structures and so to disturb the replication, could be involved in 
inducing fragility in the surrounding regions (Curatolo et al., 
2007). Nine of the genes localized within the FRA1H region, 
because of their putative role in tumor suppression function, 
were investigated for homozygous deletion in a panel of 
heterogeneous cancer cell lines (Pelliccia et al., 2007). The same 
nine genes were checked for loss or modification of their 
expression in the same panel of cancer derived cell lines. Five of 
the analyzed genes showed a significant modification in the 
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expression level. Interestingly a cluster of two microRNA, 
MIRN194-1 and MIRN215, showed a detectable expression of 
the polycistronic RNA in different leukemia and lymphoma 
derived cell line that is absent in normal lymphocyte (Pelliccia et 
al., 2007). This finding suggested that the five genes, because of 
their functions and the modifications of the level of expression 
shown in some of the analyzed cancer cell lines, could have a 
role in the neoplastic transformation of some cell type.   
Limongi et al. (2003) showed that the most fragile region 
of the FRA2G common fragile site extends over 1 Mb, at the 
2q31 region (Fig. 8). An analysis of DNA sequence spanning the 
fragile region showed a high frequency of flexibility regions 
within this site that could contribute to fragility. Furthermore, 
the Burkitt lymphoma-derived cell line DAUDI has a biallelic 
deletion that involves eight of nine genes chosen for a 
transcriptional analysis of the FRA2G genes (Fig. 8). Moreover, 
loss of expression of the DHSR9 gene was observed in two 
lymphocyte derived cell lines, MOLT-14 and Raji. 
FRA7B and FRA13C are not yet characterized. Their 
characterization would be important to continue the analysis of 
this particular class of common fragile sites. 
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Figure 7. Physical map of the FRA1H region. The BAC and PAC clones 
used as probes for its characterization, some markers and some genes are 
shown (Curatolo et al., 2007) 
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Figure 8. Physical map of the FRA2G region. The BAC clones used as 
probes for its characterization, some markers and some genes are shown 
(modified from Limongi et al., 2003). 
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AIM OF THE RESEARCH 
 
 
 
 
 Understanding the molecular basis of common fragile 
site instability is important given that these regions are 
frequently deleted or rearranged in cancer cells. Furthermore, 
common fragile sites provide a unique window into the 
molecular events that occur following certain types of 
replication stress in mammalian cells. Due largely to their 
instability in tumor cells and the link to important cell cycle 
checkpoint and DNA repair pathways, the study of common 
fragile sites has become increasingly important over the past few 
years, and a great deal has been learned about their genomic 
structure and mechanisms of instability. However, a number of 
questions remain, and future studies should enhance our 
understanding of the dynamics of common fragile sites 
replication and the significance of these conserved regions in 
normal and cancer cells. 
 Due to the lack of knowledge about chromosomal 
fragility, and to further investigate the DAPI inducible class, in 
the first part of my work, I have molecularly characterized the 
common fragile site FRA7B (Bosco et al., 2010). This 
aphidicolin and DAPI induced common fragile site was mapped 
to the terminal region of the short arm of chromosome 7 (7p22) 
(Yunis and Soreng, 1987). In detail, the DNA sequence of the 
fragile site was determined using BAC and PAC clones and 
fluorescent in situ hybridization (FISH) analysis. The molecular 
composition of the identified sequence was also analyzed and 
searched for the presence of high DNA helix flexibility regions.  
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 To investigate the relationship between DNA replication 
time and fragility, in the second part of my work I have 
investigated the timing of replication of sequences mapping 
within two DAPI inducible fragile sites FRA1H and FRA2G by 
using FISH on interphase nuclei (Pelliccia et al., 2008).  
 The last part of my work focused on the role of common 
fragile sites in the generation of genome instability. There is 
extensive evidence that common fragile sites are preferential 
loci for double strand breaks under stressful growing conditions, 
which can result in gene amplification as well as deletions and 
translocation. Myllykangas et al. (2006) performed a bibliomic 
survey to investigate DNA amplifications in different 
neoplasms. They identified frequently amplified chromosomal 
loci, and found that the amplifications are preferentially 
localized in certain genome regions and contain many cancer 
genes and fragile sites. However, also according to these 
Authors, the demonstration of the colocalization of amplification 
breakpoint regions and fragile DNA sequences needs of studies 
using molecular biology resolution. In the model of 
intrachromosomal gene amplification obtained by breaks at 
common fragile sites, the amplicons appear to be arranged in 
head-to-head organized ladders created by repeated breakage-
fusion-bridge cycles (Coquelle et al., 1997, see introduction and 
Fig. 3). Two common fragile sites may set the boundaries of the 
early amplicon: the break at the more telomeric site determining 
the telomeric loss and then the sister chromatids fusion, and the 
break at the more centromeric site defining the amplicon size. 
Common fragile sites FRA1H, FRA2G and the latest 
characterized FRA7B, are frequently breakpoints in 
chromosome aberrations in various neoplasms. At a distance of 
about 20 Mb from FRA1H, at the chromosome band 1q44, the 
common fragile site FRA1I is mapped, and about 15 Mb from 
FRA2G, at the chromosome band 2q32.1, was mapped FRA2H. 
FRA7B is mapped at the end of the short arm of chromosome 7, 
in this case a telomeric breakage could be involved in giving rise 
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to a BFB cycle. In fact, telomere dysfunction was associated to 
fusion-breakage driving to amplifications and deletions of 
cancer-relevant loci, suggesting that telomere-based crisis 
provides a mechanism of chromosomal instability (O’Hagan et 
al., 2002). 
Therefore, insofar as the entire 1q arm, the chromosome 
region 2q13-q36 and 7p13-22 had been included in the top 30 
identified amplification hotspots (Myllykangas et al., 2006), a 
panel of 21 cancer cell lines were analyzed to identify any DNA 
copy number variation affecting the region on chromosome 1 
and 2, between adjacent common fragile sites, and the region of 
chromosome 7 between FRA7B and the telomeric sequences 
(Pelliccia et al., 2010). 
The work was performed using FISH and BAC probes 
chosen in the region between fragile sites. 
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RESULTS AND DISCUSSION 
 
 
 
 
PART 1. Molecular characterization of the human common 
fragile site FRA7B 
 
 The FRA7B common fragile site is located at the 
terminal region of the short arm of chromosome 7 in such a way 
that the telomeric region is sometimes observed as being 
completely undercondensed (Fig. 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. GIEMSA stained metaphases chromosomes expressing 
the fragile site FRA7B (arrowheads). Hybridization signals of the 
BAC clones RP11-42B7 (red) and RP11-425P5 (yellow) on the 
same chromosomes stained with DAPI. 
Nazario Bosco 
Pag 38  
To analyze the fragile region and to define the 
centromeric boundary of the FRA7B sequence, a set of nine 
PAC and BAC clones were used for FISH analysis. The probes 
were selected starting from a sub-telomeric region and walking 
toward the centromere (Tab. 3) 
The undercondensed area sometimes extends as far as 
the telomere, and the telomeric probe sometimes spreads on the 
undercondensed region. Also, since telomeres are regions with 
replication problems that can display an increase in frequency of 
a fragile site-phenotype after aphidicolin treatment in metaphase 
(Sfeir et al. 2009), the question could arise as to whether it is 
correct to consider the (TTAGGG)n telomere sequence (a few 
kilobases long) as a part of the FRA7B fragile site.  
 
 
 
Table 3. Analysis of FISH signals of BAC and PAC clones and of a 
telomere probe relative to FRA7B fragile region. In gray is underlined the 
FRA7B more fragile region. 
 
Probe   N % Prox % Mid % Dist 
RP11-708O1 69 100 0.0 0.0 
RP11-507C1 71 98.6 1.4 0.0 
RP4-755G17 42 90.5 2.0 7.5 
RP11-696N1 73 80.8 4.1 15.1 
RP11-425P5 85 54.7 5.9 39.4 
RP11-42B7 75 22.7 13.3 64.0 
RP11-151M24 50 8.0 22.0 70.0 
RP11-6A1 52 5.7 23.1 71.2 
RP11-449P15 49 4.1 20.4 75.5 
(TTAGGG)n    90 0.0 18.0 80.0 
%Prox, %Mid and %Dist refer to the percentage of time that the 
hybridization signal was observed proximal to, on, and distal to the 
gap/break; N is the number of FISH observations for the probe. 
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The fluorescent signal of the telomeric (TTAGGG)n 
probe was observed as a distal (telomeric) spot to the FRA7B 
gap/breakage or to spread over the undercondensed region. The 
hybridization signals of the seven BAC were observed to lie 
proximal to, on, and distal to the FRA7B gap/breakage on 
different chromosomes (Fig. 9, Tab. 3). They are therefore 
located inside the fragile region. None of the fluorescent signal 
of the BAC clone RP11-507C1 was distal to the FRA7B gap 
(98% of proximal hybridization signals), while the fluorescent 
signals of the BAC clone RP11-708O1 were completely 
proximal (centromeric) to the FRA7B gap/breakage, so this last 
BAC is not involved in the fragility (Tab. 3). Inside the fragility 
region, a more fragile region may be identified around and 
above the BAC clone RP11-425P5. This probe presents 
hybridization signals both proximal and distal to the FRA7B 
gap/breakage with high frequency (Tab 3, Fig. 10). The fragile 
region FRA7B, from the BAC 507C1 to the telomere, is 12.2 
Mb long. 
The FRA7B sequence was then analyzed to identify 
coding sequences and some structural features possibly involved 
in fragility. FRA7B spans the distal part (~5 Mb) of the G-band 
7p21.3 and the entire band 7p22, which is subdivided at the 850-
band level of resolution, into the R-band 7p22.1, the light gray 
G-band 7p22.2, and the R-band 7p22.3 (Fig. 10). 
 Using public databases, the FRA7B DNA sequence was 
analyzed to identify coding sequences, AT content, DNA 
repeats, CpG islands, MAR, high flexibility regions. Following 
the NCBI database (Build 36.3), the FRA7B sequence was 
divided into four parts: the distal 5 Mb of the G-band 7p21.3 and 
the three sub-bands of 7p22 (Fig. 10, Tab. 4). The same analysis 
was performed on four non-fragile control sequences with GC 
content similar to each of the four fragile sequences, obtained 
from G-bands (NFRA-G) and R-bands (NFRA-R) (Tab. 4). 
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Figure 10. Physical map of the FRA7B region. The BAC and PAC clones 
used as probes for its characterization, some markers and some genes are 
shown. 
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Table 4. Chromosomal position of the analyzed fragile and nonfragile control 
sequences located in G- and R-bands (Build 36.3). 
 
 
 
First, the sequences were analyzed, 500 kb at a time, and 
the average values of AT content, DNA repeats, CpG islands, 
MAR, high flexibility regions within the four regions of interest 
and the control region were then computed. 
 Sequence analysis of characterized common fragile sites 
has revealed that very large genes are associated with 
approximately half of the fragile regions (Smith et al., 2006). 
Moreover, miRNA genes, a family of small non-coding RNAs 
involved in gene regulation, have frequently been found located 
at fragile sites (Calin et al., 2004). A total of 74 genes are 
mapped at the fragile region. Two of them are miRNA genes: 
MIRN589 (99 bp), codified within the third intron sequence of 
the gene FBXL18 (F-box and leucine-rich repeat protein 18) in 
the R-band 7p22.1, and MIRN339 (94 bp), codified within the 
7p21.3  G-b 7.2-12.2 Mb 5 Mb 
NFRA-Ga 8p22 (16.3-17.3 Mb) 1 Mb 
 12p12.3 (15-16 Mb) 1 Mb 
 13q31.1 (83-84 Mb) 1 Mb 
   
7p22.1 R-b 4.3-7.2 Mb 2.9 Mb 
NFRA-Rb 16p13.3 (4.4-5.9 Mb) 1.5 Mb 
 12p13.31 (5.0-6.5 Mb) 1.5 Mb 
   
7p22.2 G-b 2.65-4.3 Mb 1.65 Mb 
NFRA-Gc 12p13.32 (3.3-4.8 Mb) 1.5 Mb 
   
7p22.3 R-b 0-2.65 Mb 2.65 Mb 
NFRA-Rd 9q34.3 (137.2-138.2 Mb) 1 Mb 
 16p13.3 (1.4-2.9 Mb) 1.5 Mb 
   
FRA7Be R-b 7p22.2 (4370.22-4460.22 kb) 0.09 Mb 
NFRA-Re 12p13.32 (5910-6000 kb) 0.09 Mb 
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second intron of the gene C7orf50 (Chromosome 7 open reading 
frame 50) in the R-band 7p22.3. Moreover, three are large 
genes: THSD7A (thrombospondin, type 1, domain containing 
7A) (458 kb) mapped at G-band 7p21.3, the very large gene 
SDK1 (side-kick homolog 1, cell adhesion molecule) (968 kb) 
mapped at the G-band 7p22.2, and MAD1L1 (mitotic arrest 
deficient-like 1) (418 kb) at R-band 7p22.3 (Fig. 10). All these 
genes regulate important cellular functions. In particular, the 
miR-339 is involved in promoting resistance of cancer cells to 
cytotoxic T-lymphocytes (Ueda et al., 2009). Moreover, 
MAD1L1 is a component of the mitotic spindle-assembly 
checkpoint, and its dysfunction is associated with chromosomal 
instability and pathogenesis in various type of cancer (Tsukasaki 
et al., 2001). 
 The fragile sequence in the G-band 7p21.3 (5 Mb) has an 
AT average content, 63.6% ± 1.4 (P≤0.05), that represents a 
very high value for G-bands. The AT average content of the R-
band 7p22.1 (3 Mb) is 51.9% ± 3.9 (P≤0.05), which is a very 
high value for R-bands. The light G-band 7p22.2 (1.65 Mb) has 
a very low AT average content, 54.7% ± 4.4 (P≤0.05), for G-
bands. The average content of the R-band 7p22.3 (2.65 Mb), 
45.1% ± 2.3 (P≤0.05), represents a median value for R-bands 
(The BAC resource Consortium, 2001; Niimura and Gojobori, 
2002). 
 The search for putative CpG islands in the fragile regions 
shows quantities of these sequences that are not significantly 
different from that of the control sequences. 
 An analysis of the DNA repeat composition of the four 
FRA7B sequences does not display any important differences 
between these and the NFRA-G and NFRA-R control sequences 
(Fig. 11), except for the over-representation of Alu elements in 
the R-band 7p22.1. This difference is also observed in the 
comparison with standard genome sequences with similar AT 
content (Smit, 1999). 
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No significant difference in the density of potential MAR 
sequences is shown in the fragile regions in comparison with the 
control NFRA regions. 
 When the four FRA7B regions were analyzed for the 
presence of DNA helix high-flexibility regions, no significant 
differences were observed between the fragile and non fragile 
control sequences, although this analysis pointed to the presence 
of a particular region, FRA7Be, about 90 kb long (Tab. 5, Fig. 
10).  
 
 
 
Table 5. Twistflex flexibility analysis of fragile and nonfragile control 
regions (curvature threshold 13.7) 
a Group of peaks with distance between adjacent peaks ≤ 100bp 
b Three or more peaks, with distance between adjacent peaks ≤ 5kb 
 
 
 
 
 
Bands 
 
Mb 
Flexibility 
(peaks/Mb) 
Unified 
peaksa/Mb 
Cluster of 
peaksb/Mb 
7p21.3 G-b 5.0 79 41 10.4 
NFRA-Ga 3.0 71 44 6.7 
     
7p22.1 R-b 2.9 40 24 5.5 
NFRA-Rb 3.0 42 21 3.0 
     
7p22.2 G-b 1.65 41 24 2.4 
NFRA-Gc 1.5 30 18 3.6 
     
7p22.3 R-b 2.65 17 11 2.4 
NFRA-Rd 2.5 16 7 1.2 
     
FRA7Be R-b 0.09 378 133 55.6 
NFRA-Re 0.09 156 67 11.1 
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FRA7Be is localized at the telomeric edge of the 7p22.1 
R-band, just at the beginning of the more fragile region, and 
presents very high flexibility values also when compared with a 
non fragile control sequence (NFRA-Re) chosen as the richest in 
flexibility peaks from a number of examined control regions 
having the same length and AT content (Tab. 5, Fig. 12). This 
sequence, which could be considered AT rich because of its 
localization in an R-band, is not particularly AT rich (56.8%). 
However, its AT content is due overall to runs of AT-rich simple 
repeats that coincide with the flexibility peaks.   
 Using the M-fold program, the FRA7Be region was 
analyzed for its ability to form ssDNA secondary structures. 
FRA7Be is extremely favorable for forming stable secondary 
structure while the NFRAe control region doesn’t show the same 
propensity (Fig. 12). 
 
 
 
In this part of the work, the extension of the common 
fragile site FRA7B has been defined and some of its molecular 
features have been analyzed. The cytogenetic location of the 
FRA7B fragile sequence occupies most of the G-band 7p21.3 
and the whole telomeric 7p22 band (subdivided into the three 
sub-bands described at the 850-band level of resolution: the R-
band 7p22.1, the light gray G-band 7p22.2, and the R-band 
7p22.3). So, like most common fragile sites (El Achkar et al., 
2005), FRA7B lies at the interface of G- and R-bands. These 
regions are probably difficult to replicate because of the 
transition from late to early replicating DNA domains. A large 
body of evidence supports the replication-dependent instability 
of the common fragile regions. Chan et al. (2009) recently found 
that replication inhibitors such as aphidicolin induce sister 
chromatid DNA bridges as replication intermediates, specifically 
at common fragile site loci that are already regions intrinsically 
difficult to replicate. These pathologic structures, inefficiently 
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resolved before anaphase by DNA repair protein complexes, will 
lead to anaphase bridges, then to chromosome breakages, and so 
forth, to all events derived from these breakages, such as 
chromosome rearrangements, recombination, viral integrations, 
and amplifications. 
 
 
 
Figure 12. Analysis of DNA helix flexibility of FRA7Be and NFRAe control 
sequence. The flexibility peaks with curvature values above 14 are marked by 
dots. Values of curvature above 16 are marked by arrows. The horizontal axis 
indicates the size of the analyzed sequences, the vertical axis shows the 
curvature values in the DNA twist angle.  
Below are presented the M-fold analysis of the FRA7Be and NFRAe high 
flexibility regions. 
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Sequence analysis of a number of common fragile sites 
seems to indicate that the replication fork progression may be 
disturbed by highly flexible DNA sequences, so that the latter 
are believed to have an important role in fragility (Zlotorynski et 
al., 2003; Mishmar et al., 1998). Flexibility analysis of the 
FRA7B region revealed the presence of a 90 kb long sequence, 
FRA7Be, particularly rich in AT DNA stretches and in 
flexibility peaks right at the beginning of the more fragile region 
and localized at the telomeric edge of the 7p22.1 R-band. This 
sequence could have a role in inducing stalling of the replication 
and fragility in the FRA7B region due to its propensity to form 
stable secondary structures. 
 The 7p22.1 R-band, besides harboring the more fragile 
region and the FRA7Be flexible sequence, also displays a 
particular richness in Alu repeats element. It is not known 
whether there is any link between Alu richness and fragility. 
Nonetheless, even if it is debatable whether Alu repeat richness 
is the cause or the consequence of fragility, the R-band 7p22.1 
possesses particular features that could have an important role in 
generating instability in this chromosomal region.  
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PART 2. Replication timing of two human common fragile 
sites: FRA1H and FRA2G 
 
 Starting from the assumption that common fragile sites 
are regions of late or slowed replication in the presence of 
sequence elements that have the propensity to form secondary 
structures, and that the cytogenetic expression of fragile sites 
may be due to unreplicated DNA, this part of my work analyzes 
the relationship between DNA replication time and fragility.  
In particular the timing of replication of sequences 
mapping within two common fragile sites, FRA1H and FRA2G 
was investigated. These two fragile sites are both efficiently 
induced by DAPI. FRA1H (1q41-q42.1) spans about 10 Mb, and 
its expression is induced also by 5-azaC, 5-azadC, and by ad12 
(Curatolo et al., 2007). FRA2G site (2q24.3-q31) extends over 1 
Mb, and belongs to the aphidicolin induced fragile sites class 
(Limongi et al., 2003). Moreover, the timing of replication of 
syntenic non fragile sequences, and that of early and late 
replicating control sequences were analyzed by using fluorescent 
in situ hybridization on interphase nuclei. 
 In this method, before replication, each locus appears as 
a single hybridization dot signal (S) while, after replication, 
duplicated dot signals (D) are visible (Selig et al., 1992). 
 The probes used to study the replication timing of the 
FRA1H site were the BACs RP11-295M18 (FRA1Hfa) and 
RP11-351P24 (FRA1Hfb), which map within the fragile region. 
Moreover, in order to directly compare the replication time of 
the fragile sequences with a non fragile sequence localized on 
the same chromosome, cells were also hybridized with the BAC 
clone RP11-281B4 (NFRA1), which is located outside the 
fragile region (Fig. 13A) (Curatolo et al., 2007). 
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Figure 13. Maps of the FRA1H (A) and FRA2G (B) regions. Some DNA 
markers are shown. Arrows indicate the BAC used for the replication timing 
analysis by FISH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The probes used to study the replication timing of the 
FRA2G site were the BACs RP11-527A7 (FRA2Gfa) and 
RP11-551O2 (FRA2Gfb), which map within the fragile region. 
Moreover, cells were also hybridized with the BAC clone RP11-
284E18 (NFRA2), which is located outside the fragile region 
(Fig. 13B) (Limongi et al., 2003). 
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The interphase nuclei in S-phase were distinguished from 
the G1- and G2-nuclei by adding BrdU 20 min prior to cell 
harvest. Five distinct temporal S-phase stages, from early (stage 
I) to late (stage V) S phase, were identified analyzing the BrdU-
labelling patterns of the nuclear DNA replication (Fig. 14) 
(O’Keefe et al., 1992; Sadoni et al., 1999). 
 Two experimental protocols were performed for both 
FRA1H and FRA2G fragile site replication analysis. In the first 
type of experiment, the nuclei were observed by an 
epifluorescence-equipped microscope and all probes were 
hybridized in pairs and simultaneously with either the GG1 or 
Me2.5 cosmids used as early and late replicating control probes, 
respectively (Morley et al., 1991; Smith and Higgs, 1999). The 
use of these control probes with the probes of interest also 
allowed checking the comparability of results. 
The frequency of duplicated signals (D) of each probe 
was estimated for each of the five nuclear BrdU-labeling pattern 
stages. At least 200 S-phase nuclei were scored for each probe. 
The efficiency of hybridization was controlled by scoring the 
hybridization of metaphase chromosomes on each analyzed 
slide. 
In the second type of experiment, all probes were 
individually hybridized and the observations were obtained by 
confocal microscopy in order to identify both the BrdU nuclear 
and the probe-labeling pattern by three-dimensional analysis. 
Also in this case, at least 200 S phase nuclei were scored for 
each probe and the frequency of duplicated signals (D) was 
estimated for each nuclear DNA replicating pattern. 
The frequencies of D signals observed for each probe 
and for each of the five temporal replicating nuclear stages, 
obtained with the two experimental methods, did not present 
statistically significant differences and therefore the 
observations were combined. 
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All the experiments were performed in duplicate with 
and without addition of DAPI. The aim was to study the possible 
effect of DAPI, a compound that induces undercondensation of 
FRA1H and FRA2G, on replication of these two sites. No 
statistically significant differences were found between the two 
treatment types. 
The results are presented in Fig. 15. As regards the FRA1H 
site, the analysis of the frequency of D signals shows that both 
the FRA1Hf fragile sequences and the NFRA1 non fragile 
sequence initiate their duplication early at stage I of the S phase. 
Nevertheless the proportion of doublets at this stage and at the 
following stages is very different for the fragile and non fragile 
loci. FRA1Hfa and FRA1Hfb present only a few D signals 
(about 6% and 11% respectively) at stage I and the number of D 
signals increases up to about 55% and 50%, respectively at stage 
V. NFRA1 is already duplicated at stage I in about 21% of the 
cells, then the frequency of D signals increases up to 100% at 
stage V (Fig. 15).  
Likewise, as regards the FRA2G site, both the replication 
of the fragile FRA2Gf sequences and that of the non fragile 
NFRA2 sequence initiates early at stage I, but while FRA2Gfa 
and FRA2Gfb present only about 10% and 11%, respectively of 
D signals, NFRA2 presents about 32%. At stage V of the S 
phase, the proportion of doublets reaches about 43% and 57% in 
the two fragile loci, respectively and 95% in the non fragile 
locus (Fig. 15). 
 As expected, GG1 (the α-globin locus) replicates early in 
S phase (about 26% of D signals at stage I) and is almost 
completely replicated at stage V presenting about 87% of D 
signals. Also the replication of the late replicating probe Me2.5 
(β-globin locus) initiates at stage I of the S phase, but at this 
stage shows only about 2% of doublets. Moreover, at stage V, 
the proportion of D signals reaches only about 50% in this locus 
(Fig. 15). 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 53  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Percentage of double FISH dots (D) observed at the S 
phase temporal stages (I-V) for the eight probes used. 
  
 
 
 
 
 The comparative analysis of this data reveals that the 
replication of all examined loci initiates already in the earliest 
stage of S phase (stage I) but with a very different frequency in 
each analyzed locus. In fact, the four fragile sequence FRA1Hfa, 
FRA1Hfb, FRA2Gfa and FRA2Gfb, and the late replicating 
control sequence Me2.5 show a frequency of doublets ≤ 11% 
(about 6%, 11%, 10%, 11% and 2% respectively), while the 
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frequency of D signals of the two non fragile sequences, NFRA1 
and NFRA2, and of the early replicating control sequence GG1 
is ≥ 21% (about 21%, 32% and 26% respectively). Moreover, 
the first five loci, FRA1Hfa and b, FRA2Gfa and b, and Me2.5, 
reach a maximum frequency of duplicated loci of 57% at stage 
V (about 55%, 50%, 57%, 43% and 50% respectively), while at 
this same stage NFRA1, NFRA2 and GG1 are completely or in 
large parts duplicated (about 100%, 95% and 87% respectively). 
Hence, the fragile sequences and the late replicating sequence 
enter G2 phase unreplicated in about 50% of alleles. 
 Laird et al. (1987) first proposed that fragile sites 
replicate late in the cell cycle ‘perhaps extending into what is 
conventionally called G2’, failing the normal condensation and 
are therefore present as chromosome gaps in metaphase. 
Moreover, nearly all authors studying the replication timing of 
fragile sites concluded that it might be completed late in the cell 
cycle. It has been demonstrated that the replication of a small 
percentage of the genome occurs during the G2 phase (Widrow 
et al., 1998). It has also been demonstrated that checkpoint 
mechanisms exist which ensure that mitosis does not initiate 
before the replication of the genome is completed. However, low 
levels of unreplicated DNA may not be sufficient to hinder some 
cells entering mitosis (Widrow et al., 1998). Therefore very late 
replicating regions could sometimes reach mitosis unreplicated 
and be expressed as gaps/breaks. Alternatively, because of G2-
replication, these regions could be so late in condensing as to 
sometimes appear as chromosome gaps/breaks. 
 However, because not all late replicating regions are 
fragile sites, at least another structural and/or functional feature 
besides a late or slowed replication must be shared among 
fragile sequences. As mentioned above, many researchers 
assume that the presence of sequence elements potentially able 
to form secondary structures and to induce stalling of replication 
forks is a second factor promoting fragility (Arlt et al., 2003; 
Glover et al., 2005 and references cited therein). On the other 
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hand, high numbers of flexible sequences rich in AT-
dinucleotides able to form secondary structures have been found 
in most cloned common fragile sites including FRA1H and 
FRA2G (Limongi et al., 2003; Curatolo et al., 2007). 
 The inducers of fragile sites may amplify the effects of 
late replication. Aphidicolin may induce the expression of bulk 
of common fragile sites by inhibiting the DNA polymerases. In 
this case, both FRA1H and FRA2G are induced by DAPI as well 
as other compounds (see introduction). DAPI preferentially 
binds to AT-rich DNA and acts in G2 phase as an 
undercondensing agent (Prantera et al., 1981). The combination 
of late replication with the presence of sequences receptive to 
DAPI may make some fragile sites available for binding with 
this compound and thus no longer capable of undergoing normal 
condensation. 
 
 
 
 
PART 3.  Fragility and genome instability  
 
 The last part of the work focused on the consequence of 
fragile site instability in the genome, in particular in stressful 
growing cell conditions, such as cancer cells. 
 Common fragile sites are preferential loci for double 
strand breaks, which make them important factors in generating 
genome instability. This instability can result in gene 
amplification, as well as chromosome deletions and viral 
insertions (see introduction). 
 The amplification of genome regions is often observed in 
human tumors probably because it contributes to the overdosage 
of oncogenes, implicated by the pathology present in the 
amplified region.  
Many researchers have indicated common fragile sites as 
sites of chromosome breakages at the origin of breakage-fusion-
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bridge (BFB) cycles. As mentioned above, the BFB cycle can be 
initiated by breakage in one fragile site leading to the telomeric 
loss, and then the deletion, of a chromosome region. The second 
breakage that occurs after chromatid fusion, can also happen 
within a second fragile site that sets the amplicon size. 
  In this part of the work, the genome of 21 cancer cell 
lines (see Material and Methods) were analyzed for the presence 
of DNA copy number variation with breakpoints in the fragile 
sites FRA1H and FRA1I on chromosome 1, the fragile sites 
FRA2G and FRA2H on chromosome 2, and the fragile site 
FRA7B and the telomere on chromosome 7. 
 According to Myllykangas et al. (2006) the entire 1q 
arm, the chromosome region 2q12-q36, and the 7p22 region, 
have been identified as amplification hot spots in several 
cancers.  
Using FISH analysis to investigate the presence of 
amplification/deletions affecting the chromosome region 
between the common fragile sites FRA1H and FRA1I and the 
one centromeric to FRA1H, a BAC clone (RP11-385F5) located 
between the two fragile sites, and a BAC clone (RP11-434B7) 
located centromeric to FRA1H were used as FISH probes. FISH 
of the two probes on metaphase spreads of 21 tumor-derived cell 
lines (see Material and Methods) did not reveal any 
amplification nor deletions. 
 To investigate the presence of amplification/deletions 
affecting the chromosome region between the common fragile 
site FRA7B and the telomere and the one centromeric to 
FRA7B, a BAC clone (RP11-42B7) located between the fragile 
site and the chromosome end, and a BAC clone (RP11-708O1) 
located centromeric to FRA7B were used as FISH probes. FISH 
of the two probes on metaphase spreads of 21 tumor-derived cell 
lines (see Material and Methods) did not revealed any 
amplification nor deletions. 
 To investigate the regions between FRA2G and FRA2H 
and the one centromeric to FRA2G, the BAC clones RP11-
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158L8 located between the two fragile sites and the RP11-
681B22 located centromeric to FRA2G were used (Fig. 16). 
FISH with these two probes on the panel of 21 cancer cell lines 
revealed the existence of a duplicated region on a chromosome 
der(2) in two analyzed leukemia cell lines K562 (K562-1 and 
K562-2). The duplications on the two chromosomes der(2) of 
the two cell lines are of different lengths.  
The K562 cell line derives from a pleural effusion of a 
female with chronic myelogenous leukemia (CML) in terminal 
blast crisis (Lozzio and Lozzio, 1975). Different sublines that 
differ slightly in their marker set probably exist. The hallmark of 
CML is the Philadelphia rearrangement of the BCR and ABL 
genes [t(9;22)(q34;q11)] which is responsible for the BCR/ABL 
fusion gene and the expressed fusion protein that is critical in the 
neoplastic transformation (Naumann et al., 2001). 
 In the K562-1 cell line, the probes 158L8 and 681B22 
showed a normal hybridization pattern on two chromosomes 2, 
while on the long arm of a third chromosome [der(2)-1] 
duplicated signals appeared in the following order: centromere-
681B22-158L8-158L8-681B22-telomere (Figs. 17A and 18A). 
 To define the size of the duplicated region and to 
precisely identify its boundaries and thus the breakpoints 
involved in its origin, FISH experiments were performed using 
two sets of BACs, one set distal (telomeric) to 158L8 (335G13, 
489J10, 363G3) and the other set proximal (centromeric) to 
681B22 (472M4, 341F20, 375H16, 364H22) (Fig. 16). 
With regard to the BAC set distal to 158L8, the analysis 
of the FISH signals revealed very close fluorescent duplicated 
dots of the probe 335G13 and the absence of signals for the 
probes 489J10 and 363G3. These results place the breakpoint 
and thus the telomeric boundary of the duplication in the region 
between the sequences covered by the probes 335G13 and 
489J10 in the band 2q32.1 (Fig 18A). The common fragile site 
FRA2H is mapped in this band (Fig. 16). 
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Figure 16. Map of part of the long arm of chromosome 2 showing the BAC 
cloned used as probes for FISH experiment, and the localization of FRA2H, 
FRA2G and FRA2S. 
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Figure 17. Some of the FISH experiment showing the existence of the 
inverted duplication on the chromosome der(2)-1 (A-C) and der(2)-2 (D-F). 
(A) the palindromic arrangement of the clones 681B22 (yellow) and 158L8 
(red). (B) the palindromic arrangement of the clones 375H16 (yellow) and 
158L8 (red), note moreover that the telomeric fluorescent signal of the probe 
375H16 is consistently less intense than the centromeric signal, indicating that 
the sequence is partially deleted. (C) the presence of the telomeric signal of the 
TTAGGGn probe (yellow) on telomere of the rearranged der(2)-1 identified by 
the duplicated signals of the 158L8 probe (red).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(D) on the chromosome der(2)-2 only the probe 158L8 (red) displays 
duplicated signals, while the 681B22 (yellow) has a single signal. (E) the 
palindromic rearrangement of the clones 11N16 (yellow) and 158L8 (red). 
(F) the presence of telomeric sequences (yellow) on the der(2)-2 identified 
with the 11N16 probe (red). 
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Figure 18. The two chromosome der(2)-1 (A) and der(2)-2 (B) are 
represented. The two wavy lines indicate the breakpoints at the origin of the 
two rearranged chromosomes. 
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With regard to the proximal BAC set (centromeric) to 
681B22, fluorescent signals of the probes 472M4, 341F20 in the 
order and position expected for a normal chromosome 2 were 
observed, while the probes 364H22 and 375H16 showed 
fluorescent duplicated signals in the following order: 
centromere-472M4-341F20-375H16-364H22-364H22-375H16-
telomere. Moreover, the telomeric fluorescent signal of probe 
375H16 was consistently less intense than the centromeric 
signal, indicating that is partially deleted (Figs. 17B and 18A). 
These results place the centromeric boundary of the duplication 
in the region covered by the clone 375H16 in the band 2q23.1. 
No common fragile sites have been mapped to this chromosomal 
region so far. 
 To investigate the structure of the telomeric region of the 
chromosome der(2)-1 a telomeric probe (TTAGGG)n was 
hybridized to detect the presence of telomeric sequences to cap 
the rearranged chromosome. This probe produced normal 
fluorescent signals on the telomeres of all chromosomes, 
including the der(2)-1 chromosome (Fig. 17C). Hypothesizing 
that the subtelomeric and the terminal part of the der(2)-1 could 
arise from reacquiring the sequences originating on the normal 
chromosome 2, a BAC probe (RP11-351E10) mapping at the 
subtelomeric region of 2q was hybridized. The signals of this 
probe were found on the two normal chromosomes 2, but not in 
the der(2)-1.  
 Interestingly, using the probes 1132H12 and 835J22, two 
sequences localized in the ABL gene that maps on chromosome 
9, and the probe 434O9, a sequence localized in the BCR gene 
that is mapped at the chromosome 22, all these three probes 
hybridize on the terminal region of the chromosome der(2)-1 
(Fig. 19A). This chromosome almost certainly corresponds to 
the marker chromosome named M1 by Naumann et al. (2001) 
and possesses the BCR/ABL fusion gene.  
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The three probes 1132H12, 835J22 and 434O9 hybridize 
with two acrocentric marker chromosomes, which were thus 
entirely composed of repeated BCR/ABL fusion genes, and 
which certainly correspond to the marker chromosome M20 
described by Naumann et al. (2001).  
Moreover, as these Authors described, the probes of the 
ABL gene marked also both the telomeric regions of a 
submetacentric marker chromosome (M7) and one telomeric 
region of an acrocentric marker chromosome (M8) (Fig. 19A). 
 It may be concluded from these observation that the 
der(2)-1 chromosome has an invdup(2)(q23.1q32.1) and a 
del(2q32.1→tel) (Fig. 18A). 
The duplicated region on the der(2)-1 spans about 38 Mb. Sixty-
six genes here localized are indicated as possibly implicated in 
cancer, two genes, ATF2 (activating transcription factor 2) and 
MIRN10B (microRNA-10b) have been implicated in cancer 
(Dessen et al., 2010). MIRN10B, the expression of which is 
upregulated in a number of neoplasms, including AML (acute 
myeloid leukemia), maps to the HOXD cluster, a family of 
transcription factor genes that play crucial roles during normal 
development and in oncogenesis. 
In the K562-2 line, the probes 158L8 and 681B22 
showed a normal hybridization pattern on two chromosome 2, 
while on the long arm of a third chromosome [der(2)-2] only the 
probe 158L8 displayed duplicated signals in the following order: 
centromere-681B22-158L8-158L8-telomere (Fig. 17D). The 
palindromic arrangement of the BAC 158L8 suggests that, also 
in this case, one BFB cycle has occurred and that the break and 
the subsequent chromatid fusion event are located at a site 
telomeric to the 158L8 probe, although the absence of a 
duplicated signal of the probe 681B22 indicates the presence on 
this chromosome of a narrower duplicated region than that 
observed in the der(2)-1 of the K562-1 line (Fig. 18B) 
 To precisely define the duplicated region and to identify 
the first breakage site, telomeric to the 158L8 probe, 
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experiments were performed as described for the K562-1 line, 
yielding the same results. Therefore, also in the der(2)-2 
chromosome, the telomeric boundary of the duplication is 
localized in the region between the sequences covered by the 
probes 335G13 and 489J10 in the band 2q32.1 in which the 
common fragile site FRA2H is mapped (Fig.16). To identify the 
centromeric boundary of the duplication, a new set of probes 
was used, localized in the region between 681B22 and 158L8 
(11M1, 11N16, 527A7, 551O2, 724O16, 193F16, 227L6) 
(FIg.16).  
All the probes, except the probe 11M1, which displayed a single 
hybridization signal, showed duplicated signals in the following 
order: centromere-11M1-11N16-527A7-551O2-724O16-
193F16-227L6-227L6-193F16-724O16-551O2-527A7-11N16-
telomere (Figs. 17E and 18B). 
 These results place the centromeric boundary of the 
duplication in the region between the sequences covered by the 
probes 11M1 and 11N16 in the 2q24.3 band.  
 From these observations it can be concluded that the 
der(2)-2 chromosome has an invdup(2)(q24.3q32.1) and a 
del(2q32.1→tel) (Fig. 18B). 
 Unlike the der(2)-1 chromosome, no FISH signals were 
obtained on the terminal region of the chromosome der(2)-2 
with the probes 1132H12 and 835J22 (sequences of the ABL 
gene) and 434O9 (sequence of the BCR gene). These probes 
hybridized on other marker chromosomes as described for the 
K562-1 line (Fig. 19B).  The telomeric probe (TTAGGG)n 
produced normal fluorescent signals on the telomeres of all 
chromosomes, including the der(2)-2 chromosome, thus 
demonstrating that a recapping of the chromosome end has 
occurred (Fig. 17F). 
 The duplicated region of the chromosome der(2)-2 spans 
about 19 Mb and represents a part of the duplicated region on 
the chromosome der(2)-1. 
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 The chromosome der(2)-2 could be derived from the 
chromosome der(2)-1 by deletion of the duplicated region owing 
to a break occurring at 2q24.3 (Fig. 18). 
 Thirty-eight of the genes localized here are indicated as 
potentially implicated in cancer. The region contains the two 
genes, ATF2 and MIRN10B, which have already been implicated 
in cancer and the HOXD cluster as mentioned above (Dessen et 
al., 2010). 
 Except for the chromosome der(2)-2, the analysis of the 
trypsin G-banded metaphases displays a karyotype very similar 
to that of K562-1 cell line. 
The results assigned to a precise region of the band 
2q32.1 the telomeric breakpoint causing the chromatid fusion 
event of the BFB cycle at the origin of the inverted duplication 
observed on both chromosomes der(2)-1 and der(2)-2, which are 
present in the cell lines K562-1 and K562-2 respectively. 
FRA2H has been mapped at the same band 2q32.1 (Yunis and 
Soreng, 1984), an aphidicolin-inducible common fragile site yet 
to be molecularly characterized. To verify that the above-
mentioned breakpoint was really located in FRA2H, the 
sequence of this fragile site was determined using the same 
approach used to define the fragile sequence of the common 
fragile site FRA7B (see Part 1). 
 
 FISH analysis was performed on metaphase spreads 
expressing FRA2H with a panel of seven probes (397C2, 
418N16, 315C24, 335G13, 489J10, 88L20, 317J9) spanning 
about 10.3 Mb (Fig. 16), a region somewhat wider than the band 
2q32.1. The BAC clone 397C2 gave only proximal 
hybridization signals while the BAC 317J9 gave only distal 
signals to the gap/breakage (Tab. 6). Five BAC clones, 418N16, 
315C24, 335G13, 489J10, 88L20, showed hybridization signals 
proximal to, on, and distal to the FRA2H gap/breakage (Tab. 6, 
Fig. 20); they therefore span this fragile site, which may be 
estimated as about 8 Mb long. 
Nazario Bosco 
Pag 66  
FRA2H spreads over most of the G-band 2q32.1 (6.5 
Mb) and over 1.5 Mb of the R-band 2q32.2. Within the fragile 
region, a more fragile region may be identified between the 
BAC 315C24 and 335G13, which present hybridization signals 
both proximal and distal to the FRA2H gap/breakage with high 
frequency (Tab. 6, Fig. 21).  
 
 
Table 6. Analysis of FISH signals of BAC clones relative to FRA2H fragile 
region. In gray is underlined the FRA2H more fragile region. 
 
Probe   N % Prox % Mid % Dist 
RP11-397C2 45 100 0.0 0.0 
RP11-418N16 50 98.0 2.0 0.0 
RP11-315C24 90 63.3 12.2 24.5 
RP11-335G13 48 43.8 25.0 31.2 
RP11-489J10 58 10.3 6.9 82.8 
RP11-88L20 51 5.1 0.0 94.9 
RP11-317J9 57 0.0 0.0 100.0 
%Prox, %Mid and %Dist refer to the percentage of time that the 
hybridization signal was observed proximal to, on, and distal to the 
gap/break; N is the number of FISH observations for the probe. 
 
 
Figure 20. FISH of the clones 315C24 (red) and 335G13 (yellow) on 
chromosome 2 expressing FRA2H, the arrowhead indicate the FRA2H break. 
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These results confirm that the breakpoint, and therefore 
the telomeric boundary of the duplicated regions of the marker 
chromosomes der(2)-1 and der(2)-2, which were identified in the 
region between the sequences spanned by the probes 335G13 
and 489J10, is actually localized in the common fragile site 
FRA2H. 
The FRA2H DNA sequence was analyzed in order to 
identify coding sequences and a number of molecular and 
structural features (AT content, DNA repeats, CpG islands, 
MARs, high flexibility regions) possibly involved in fragility.  
The fragile sequence was divided into two parts for the 
analysis, the 6.5 Mb of the G-band 2q32.1 and the 1.5 Mb of the 
R-band 2q32.2. The same sequence analysis was performed on 
two non fragile control sequences with GC content similar to 
each of the two fragile sequences, obtained from G-bands 
(NFRA-G) and R-bands (NFRA-R) (Tab. 7). The sequences 
were analyzed 500 kb at a time, and the average values of the 
two regions of interest and of the control regions were then 
calculated. 
 
 
 
Table 7. Chromosomal position of the analyzed fragile and nonfragile control 
sequences located in G- and R-bands (Build 36.3). 
G-bands   
  FRA2H-G 2q32.1 (182.9-189.4 Mb) 6.5 Mb 
  NFRA-G 8p22 (16.3-17.3 Mb) 1 Mb 
 12p12.3 (15.1-16.1 Mb) 1 Mb 
 13q31.1 (84.1-85.1 Mb) 1 Mb 
   
  FRA2Hf 2q32.1 (185265-185375 kb) 0.11 Mb 
  NFRAf-G 13q31.3 (83622-83732 kb) 0.11 Mb 
R-bands   
  FRA2H-R 2q32.2 (189.4-190.9 Mb) 1.5 Mb 
  NFRA-R 12p12.2 (20.2-21.2 Mb) 1.0 Mb 
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Figure 21. Physical map of the FRA2H region. The BAC clones used as probes 
for its characterization, some markers and some genes are shown 
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Twenty-two validated and reviewed genes are mapped in 
the fragile region. Nine of them are classified as possibly 
implicated in cancer, while two genes, DIRC1 (disrupted in renal 
carcinoma 1) and PMS1 (postmeiotic segregation increased 1) 
are indicated as genes implicated in cancer (Dessen et al., 2010). 
Moreover, two of these genes are miRNA genes: MIRN589 (97 
bp) codified within the first intron of the gene GULP1 
(engulfment adaptor PTB domain containing 1), and MIRN1245 
(70 bp) codified within the first intronic sequence of the gene 
COL3A1 (collagen, type 3, alpha 1) (Fig. 21).  
The AT average content of the G-band 2q32.1, 64.2 ± 
1.3 (P≤0.05), is a high value for a G-band; and the AT average 
content of the R-band 2q32.2, 63.8 ± 0.9 (P≤0.05), represents an 
unusually high value for an R-band (Niimura and Gojobori, 
2002). Investigation of the fragile sequences for putative CpG 
islands, density of potential MAR, DNA repeat composition, and 
DNA helix high flexibility regions produced values that were 
not significantly different from that of the non fragile control 
sequences. 
Nevertheless, this last analysis revealed the presence of a 
sequence (FRA2Hf) of about 110 kb long, that was very AT-rich 
(66.6%) and localized in the more fragile region, which presents 
very high flexibility values (Fig. 22). 
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The results presented above place the centromeric 
boundary of the invdup(2)(q23.1q32.1), identified in the der(2)-
1 chromosome (K562-1 line), in the band 2q23.1, precisely in 
the region spanned by the clone 375H16. To date, no fragile site 
has been mapped at this locus. Human lymphocytes from 
cultures of peripheral blood of five healthy individuals induced 
by aphidicolin to express fragility, were analyzed by FISH using 
as probes, besides the BAC clone 375H16, the two BACs 
341F20 and 364H22, proximal and distal to 375H16, 
respectively (Fig.16). The analysis of 150 chromosome 
gap/breaks (mean = 4.1%; range 2.1-7.2) revealed that in all five 
individuals analyzed the three probes reside within a fragile 
region. Indeed, their hybridization signals appeared proximal to, 
on and distal to a gap/breakage (Fig. 23, Tab. 8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. FISH of the clones 364H22 (red) and 341F20 (yellow) on 
chromosome 2 expressing FRA2S, the arrowhead indicate the FRA2S 
localization. 
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Table 8. FISH analysis of BAC clones on chromosomes expressing FRA2S. 
 
Probe   N % Prox % Mid % Dist 
RP11-341F20 82 21.9 34.2 43.9 
RP11-375H16 69 31.1 31.0 37.9 
RP11-364H22 74 8.1 0.0 91.9 
%Prox, %Mid and %Dist refer to the percentage of time that the 
hybridization signal was observed proximal to, on, and distal to the 
gap/break; N is the number of FISH observations for the probe. 
 
 
 
 
The region delimited by the three BACs used spans 
about 3.8 Mb. The percentage of gaps/breaks occurring distal to 
the fluorescent signals of the three probes indicates that the 
telomeric border of the BAC 364H22 almost defines the distal 
limit of the fragile region, while the proximal (centromeric) limit 
is localized centromeric to the BAC 341F20 in the G-band 
2q22.3 (Tab. 8, Fig. 23).  
This finding indicates that the fragile region identified at 
2q22.3-q23.3 is a new aphidicolin inducible common fragile 
site. Mrasek and colleagues (2010) concomitantly named 
FRA2S, a breakage localized in the 2q23 region in a screening 
for aphidicolin-inducible fragile sites. We decided to adopt this 
alphabetical nomenclature for the common fragile site 
molecularly mapped by us at 2q22.3-q23.3. At the 2q22.3 band 
Mattei et al. (1987) mapped the rare fragile site FRA2K by 
cytogenetic detection. 
 The centromeric boundary of the invdup(2)(q24.3q32.1), 
identified in the der(2)-2 chromosome (K562-2 line), in the 
terminal part of the band 2q24.3, precisely in the region 
localized between the sequences covered from the BAC clones 
11M1 and 11N16, a region that is 100 kb proximal to the 
common fragile site FRA2G (Limongi et al., 2003). FISH 
experiments, performed using the probes 11M1 and 11N16 on 
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chromosomes from cultures of peripheral blood of healthy 
individuals induced by aphidicolin to express FRA2G (100 
gaps/breakages observed), revealed that the fluorescent signals 
of both the probes were never distal to the gap/breakage but, in 
small percentages (2% and 4% respectively), on the 
gap/breakage. This region seems to represent the real proximal 
part of the FRA2G fragile site, a part that is rarely involved in 
gap/break events. Thus, this breakpoint can also be localized in a 
common fragile site. 
   At a molecular level resolution, these findings add 
weight to the already substantial evidence that the common 
fragile sites, as preferential loci for chromosome breakages and 
telomere loss, have an important role in generating chromosome 
amplification associated with the neoplasia. 
 The duplicated regions on the two chromosomes der(2)-1 
and der(2)-2, share the telomeric breakpoint and thus the fusion 
point of sister chromatids, but have two different centromeric 
boundaries, that leads to different lengths in the amplified 
region. The three breakpoints are localized in the sequence of 
three common fragile sites: FRA2H, FRA2S and FRA2G. 
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CONCLUSIONS 
 
 
 
 
In this work various aspects of common fragile site were 
analyzed, with particular attention to the family of common 
fragile sites induced by DAPI. 
First, the FRA7B fragile site was molecularly 
characterized (Bosco et al., 2010). The sequence analysis 
showed that in this region are mapped many genes that could 
have a role in neoplastic transformation. Two microRNA genes 
(miR-589 and miR-339) and MAD1L1 have already been 
associated with some types of cancer. It will be interesting to 
study the pattern of expression of these and other genes of the 
FRA7B region in different cancer cell lines in order to 
investigate for homozygous deletions or for modification or loss 
of gene expression.  
 
The replication analysis of the FRA1H and FRA2G sites 
showed that these two common fragile site are late/slow 
replicating (Pelliccia et al., 2008). This replication pattern 
confirms the hypothesis for the induction of these sites by DAPI. 
The combination of late replication (due to formation of 
secondary structures at high flexibility islands) with the presence 
of sequences receptive to DAPI make this class of fragile sites 
available for binding with this compound and thus no longer 
capable of undergoing normal condensation.  
In fact, the addition of DAPI does not change the time of 
replication of these regions since its action is mediated in the G2 
phase, during chromosome condensation. 
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The replication time analyses of the fragile site FRA7B 
will be done to further confirm this model. 
The last part of the work adds weight to the already 
substantial evidence that the common fragile sites, as 
preferential loci for chromosome breakages and telomere loss, 
have an important role in generating chromosome amplifications 
associated with neoplasia. Here, we have molecularly defined 
the localization of the breakpoints at the origin of the duplicated 
chromosome region found on the chromosomes der(2)-1 and 
der(2)-2 present in two CML cell lines K562-1 and K562-2. The 
three breakpoints are localized in the sequences of three 
common fragile sites (Pelliccia et al., 2010). 
 
Finally, this work presents FISH as an important 
multifunctional tool for the analysis of various biological 
processes, as an indispensable cytogenetic tool to identify 
specific sequences on chromosomes, and also for other different 
application, such as the IF-FISH used in this work to analyze the 
replication timing of genome sequences. 
Many modern and sophisticated technique during the 
past few years have been developed to study chromosome 
structure and to karyotype cells, such as microarray and 
comparative genomic hybridization (CGH). But like all the 
macroscopic approaches to biological processes they lacks of 
sensitivity. FISH analysis remains a useful tool to study in depth 
and to precisely identify the breakpoints involved in many 
different chromosome rearrangements.  
For example, the K562 cell line has already been 
analyzed by Naumann et al. (2001) in a combined analysis of G-
banding, multiplex-fluorescent in situ hybridization (M-FISH) 
and comparative genomic hybridization (CGH). The M-FISH 
analysis of this line did not reveal the enh(2)(q23→q31) because 
the chromosome der(2) appears as a single stained chromosome 
whose length doesn’t differ from normal chromosomes 2, with 
an exception made for the BCR/ABL fusion gene at the telomeric 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 77  
edge (Fig. 24). In the same work, the CGH analysis of the cell 
line revealed the presence of an amplified region that was 
interpreted as the BCR/ABL fusion gene present at the end of 2q 
and part of the chromosome 2 sequence present in the M17. 
 
 
        Figure 24. M-FISH of a representative K562 cell (from Neumann et al., 2001). 
 
 
 
 
The analysis by FISH of this cell line showed the 
presence of an undiscovered amplified region that is much 
bigger than the simple telomeric presence of the BCR/ABL gene. 
The FISH technique is still a useful tool to study at a molecular 
level the chromosome structure, giving a higher resolution for 
chromosome rearrangements. 
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MATERIAL AND METHODS 
 
 
 
 
1. Human lymphocytes primary cultures 
Phytohaemagglutinin-stimulated human lymphocytes from 
peripheral blood were cultured for 72 hours, in RPMI1640 
medium supplemented with 10% fetal calf serum and 2 mM L-
glutamine at 37°C in 5% CO2. To obtain metaphase 
chromosomes expressing the aphidicolin-inducible fragile sites, 
aphidicolin (0.4 µM) and ethanol (0.5%) were added to cultures 
24 hours before fixing. To induce the DAPI-inducible fragile 
sites, DAPI (50 µg/ml) was added to cultures 20 hours before 
fixing. 
 
2. Cell lines 
A panel of 21 cancer cell lines was used. The cancer cell lines 
were derived from T cell acute lymphoblastic leukemia 
(LOUCY, MOLT-14 and PEER), Burkitt’s lymphoma (DAUDI 
and RAJI), chronic myelogenous leukemia (two lines K562 by 
us named in this work K562-1 and K562-2), acute monocytic 
leukemia (MV4-11), erythroleukemia (HEL), colon carcinomas 
(DLD1, HCT116, SW620, CaCo2, HT29, LoVo and SW48), 
ovary adenocarcinoma (A2780), prostate carcinoma (DU145), 
endometrium carcinoma (HEC1A), cervix cacinoma (HeLa) and 
liver carcinoma (Hep-G2). 
The lines LOUCY, MOLT-14, PEER, DAUDI, RAJI, K562, 
MV4-11, HEL were grown in RPMI1640 with 2 mM L-
glutamine, 10% fetal bovine serum at 37°C in 5% CO2; the 
tumor cell lines A2780, DU145, DLD1, HCT116, SW620, 
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CaCo2, HT29, LoVo, SW48, HEC1A, HeLa and Hep-G2 were 
grown in D-MEM High glucose with 2 mM L-glutamine, 10% 
fetal bovine serum at 37°C in 5% CO2. 
 
3. Spreads preparation  
Colchicine (10-4 M) was added to cell culture 1-2 hours before 
harvesting. After incubation cells were harvested and treated 
with hypotonic solution (KCl 0.075M) for 8’ at 20-22 °C. Cells 
were than fixed in cold methanol/acetic acid (3:1) and dropped 
on clean slides. Air-dried slides were kept at 20-22°C for aging 
and stored at 4°C for no longer than 4-6 months. 
 
4. Probes and in situ hybridization 
4.1 Cellular culture of E. coli and DNA extraction 
BAC and PAC clones were used as probes for FISH 
experiment (see table below). The clones were selected by NCBI 
database (http://www.ncbi.nlm.nih.gov) and Ensembl Human 
Genome database (http://www.ensembl.org). The BAC and PAC 
clones were gently supplied from Dr. Mariano Rocchi, 
University of Bari (Italy), and/or ordered from Children’s 
Hospital Oakland Research Institute (Oakland, CA). 
Each colony was grown in selective LB medium at 37°C. 
To extract the BAC/PAC DNA, the bacteria were suspended in 
50 mM Tris-HCl pH 8.5, 10 mM EDTA ph8; than treated with 
0.2 M NaOH, 1% SDS and neutralized with 7.5 M 
CH3COONH4. DNA was precipitated and then resuspended in a 
suitable volume of TE pH 8 and RNase 50 µg/ml. 
The BAC and PAC clones used for the molecular 
characterization of the common fragile site FRA7B were: RPCI-
11 449P15 (AC073957), RPCI-11 6A1 (AC006433), RPCI-11 
151M24 (AC024028), RPCI-11 42B7 (AC017000), RPCI-11 
425P5 (AC009412), RPCI-11696N1 (AC004861), RPCI-4 
755G17 (AC004879), RPCI-11 507C1 (AC007321), RPCI-
708O1 (AQ516891-AQ408541). 
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The six BAC clones from the RPCI-11 library used for 
the replication timing analysis were: 295M18 (AL445423), 
351P24 (AL513363), 281B4 (AQ507541), 527A7 (AC008177), 
551O2 (AC008178), 284E18 (AC008065). The two cosmids 
used as early and late replicating control probes, were: GG1 
(Smith and Higgs, 1999) and Me2.5 (Morley et al., 1991). 
 To investigate the presence of amplification events, the 
following probes were used: for FRA1H and/or FRA1I, the two 
BAC clones RP11-385F5 (AL359921) and RP11-434B7 
(AL838261) were used, the BAC clones RP11-158L8 
(AC073465) and RP11-681B22 (AC093684) were used for 
FRA2G/FRA2H, and 42B7 and 755G17 for FRA7B and the 
telomeric region. 
 To define the distal and proximal breakpoints of the 
duplicated regions identified on the marker chromosomes der(2) 
of the two analyzed cancer cell lines K562, other BAC clones 
were selected: to define the distal (telomeric) breakpoint were 
used 335G13 (AC097500), 489J10 (AC013445), 363G3 
(AC092638), 351E10 (AC134880),  to define the proximal 
(centromeric) breakpoint in the K562-1 cell line were used 
472M4 (AC017082), 341F20 (AC013406), 375H16 
(AC016731), 364H22 (AC005036); for the K562-2 cell line 
were used 11M1 (AC011178), 11N16 (AC018932), 527A7 
(AC008177), 551O2 (AC008178), 724O16 (AC093899), 
193F16 (AC009953) and 227L6 (AC078883). 
 To investigate the telomeric regions of the chromosomes 
der(2) of the two K562 cell lines two PAC probes (RPCI-5 
1132H12 and RPCI-5 835J22), two BAC probes [434O9 
(AQ584543-AZ303188) and 351E10 (AC134880)], and a 
telomeric probe (TTAGGG)n were used. 
 To define the fragile sequence of FRA2H, a set of seven 
BAC clones was used: 397C2 (AC104076), 418N16 
(AC010888), 315C24 (AC093639), 335G13 (AC097500), 
489J10 (AC013445), 88L20 (AC012488) and 317J9 
(AC079777). 
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 The new common fragile site FRA2S was identified by 
FISH using the BAC probes 341F20 (AC013406), 375H16 
(AC016731) and 364H22 (AC005036) on metaphase spreads 
from cells of peripheral blood of five different healthy 
individuals induced with aphidicolin to express fragility. 
 
4.2. Telomeric Probe 
 (TTAGGG)n probe was obtained by PCR using the 
protocol proposed by Ijido et al. (1991). PCR is carried in the 
absence of template using primers (TTAGGG)5 and 
(CCCTAA)5. Staggered annealing of the primers provides a 
single strand template for extension by Taq polymerase. PCR 
reactions were performed in 100 µl volumes containing 50 mM 
KCl, 10 mM Tris pH 8.3, 1.5 mM MgCl2, 200 µM each 
nucleotide, 0.1 µM of each primer and 2 U of Taq polymerase. 
Amplification consisted of first 10 cycles of 1 min each at 94°C, 
30 sec at 55°C and 1 min at 72°C, followed by 30 cycles each 1 
min at 94°C, 30 sec at 60°C, 90 sec at 72°C, and one final step 
of 5 min at 72°C.  
 
4.3. Nick Translation (NT) 
 Each clone and telomeric PCR product was labeled with 
biotin-16-dUTP or Digoxigenin-11-dUTP (ROCHE) by nick 
translation in a ratio of 65% modified nucleotide and 35% dTTP. 
For each nick translation reaction mix 1 µg of DNA was labeled 
for 2 hours at 15°C in NT buffer (1M Tris pH 8, 1M MgCl2, 
BSA 100 mg/ml), with dNTP mix, 0.1M β-Mercaptoethanol, 
0.02 U DNase I, 10 U E. coli DNA polymerase I, in order to 
obtain labeled fragments in the range of 300-600 bp. 
 
4.4. Fluorescent in situ hybridization 
 For each FISH, 200 ng of labeled probe pre-annealed 
with CotI DNA (Invitrogen) was used. Slides were denatured in 
70% formamide, 2xSSC at 80°C with bio/dig labeled probe. 
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Hybridization was carried overnight at 37°C in a moist chamber. 
Post-hybridization washes were performed at 60°C in 1xSSC. 
 
4.5. Detection of probes 
 Biotin-labeled probes were detected with Cy3-
conjugated avidin, and digoxigenin-labeled probes were detected 
with FITC-conjugated antidigoxigenin antibody. Slides were 
counterstained with DAPI (4’-6-diamidino-2-phenylindole, 
SIGMA). The images were recorded using a ZEISS Axioscope 
epifluorescence microscope equipped with a CCD camera and 
then merged using the Adobe Photoshop Software. 
 
5. BrdU labeling 
 To identify the S-phase nuclei by immunolabeling 
detection, the cell cultures were supplied with BrdU (10-5 M), 20 
min before fixing. S phase BrdU-labelled nuclei were visualized 
by indirect immunofluorescence immediately after FISH. Slides 
were incubated with 1 µg/ml of anti-BrdU  antibody 
(Calbiochem) in PBS, 5% fetal calf serum for 1 hour. Slides 
were than incubated for 30 min with 15 µg/ml FITC-conjugated 
antimouse IgG (Vector Labs). Epifluorescence images were 
captured using a ZEISS Axioscope microscope equipped with a 
CCD camera. For confocal imaging a LEICA TMIRE2 inverted 
confocal microscope was used. The images were merged using 
the Adobe Photoshop Software. 
 
6. Sequence analysis of fragile regions 
 The AT content and the composition in DNA repeted 
elements was analyzed using the RepeatMasker program 
(http://www.repeatmasker.org/cgi-bin/WEBRepeatMasker/), a 
program that screens DNA sequences for interspersed repeats 
and low complexity DNA sequences.  
 Matrix Attachment Regions (MARs) were identified 
using the MAR-Wiz program 
(http://www.genomecluster.secs.oakland.edu/marwiz/). 
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 CpG islands [observed/expected ratio >50, length >200 
base pairs] were identified using the CPGPLOT program 
(http://www.ebi.ac.uk/emboss/cpgplot). 
 High flexibility regions were identified using the 
TwistFlex program (http://margalit.huji.ac.il/) that measures the 
local variations in the DNA structure and evaluates DNA 
flexibility, expressed as fluctuations of the DNA twist angle. 
The analysis was performed in overlapping windows of 100 bp. 
Adjacent overlapping windows with twist angle-scores 
exceeding 13.7° are referred as ‘flexibility peaks’. When the 
distance within the last base of one peak and the first base on the 
next peak is smaller than the window size, these two peaks are 
considered as one single ‘unified peak’. TwistFlex can also 
identify ‘clusters’ of flexibility peaks, which are at least three 
flexibility peaks that cover a window < 5 kb (Zlotorynski et al., 
2003). 
 Predicted secondary structures formation of the flexible 
regions was performed using M-fold program 
(http://www.mfold.rna.albany.edu/mfold). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 85  
 
 
 
REFERENCES 
 
 
 
 
Andreassen PR, D’Andrea AD, Taniguchi T (2004). ATR 
couples FANCD2 monoubiquitination to the DNA-damage 
response. Genes Dev, 18: 1958-1963. 
 
Anglana M, Apiou F, Bensimon A, Debatisse M (2003). 
Dynamics of DNA replication in mammalian somatic cells: 
nucleotide pool modulates origin choice and interorigin spacing. 
Cell, 114: 385-394. 
 
Aqeilan RI, Trapasso F, Hussain S, Costinean S, Marshall D, et 
al. (2007). Targeted deletion of Wwox reveals a tumor 
suppressor function. Proc Natl Acad Sci U.S.A., 104: 3949-
3954. 
 
Arlt MF, Miller DE, Beer DG, Glover TW (2002). Molecular 
characterization of FRAXB and comparative common fragile 
site instability in cancer cells. Genes Chromosome Cancer, 33: 
82-92. 
 
Arlt MF, Casper AM, Glover TW (2003). Common fragile sites. 
Cytogenet Genome Res, 100: 92-100. 
 
Arlt MF, Xu B, Durkin SG, Casper AM, Kastan MB, Glover 
TW (2004). BRCA1 is required for common fragile-site stability 
via its G2/M checkpoint function. Mol Cell Biol, 24: 6701-6709. 
 
Nazario Bosco 
Pag 86  
Arlt MF and Glover TW (2010). Inhibition of topoisomerase I 
prevents chromosome breakage at common fragile sites. DNA 
Repair, 9: 678-689. 
Barnes LD, Garrison PN, Siprashvili Z, Guranowski A, 
Robinson AK, et al. (1996). Fhit, a putative tumor suppressor in 
humans, is a dinucleoside 5’,5’’’-P1,P3-triphosphate hydrolase. 
Biochemistry, 35: 11529-11535. 
 
Bednarek A, Keck-Waggoner CL, Daniel RL, Laflin KJ, 
Bergsagel PL, et al. (2001). WWOX, the FRA16D gene, behaves 
as a suppressor of tumor growth. Cancer Res, 61: 8068-8073. 
 
Bois P and Jeffreys AJ (1999). Minisatellite instability and 
germline mutation. Cell Mol Life Sci, 55: 1636-1648. 
 
Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, 
Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, 
Mullokandov MR, Klinger H, Drabkin HA (1997). Chromosome 
3p14 homozygous deletions and sequence analysis of FRA3B. 
Hum Mol Genet, 6: 193-203. 
 
Bosco N, Pelliccia F, Rocchi A (2010). Characterization of 
FRA7B, a human common fragile site mapped at the 7p 
chromosome terminal region. Cancer Genet Cytogenet, 202: 47-
52. 
 
Calin GA, Sevignani C, Dimitru CD, Hyslop T, Noch E, et al. 
(2004). Human microRNA genes are frequently located at 
fragile sites and genomic regions involved in cancers. Proc Natl 
Acad Sci U.S.A., 101: 2999-3004. 
 
Casper AM, Nghiem P, Arlt MF, Glover TW (2002). ATR 
regulates fragile site stability. Cell, 111: 779-789. 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 87  
Casper AM, Durkin SG, Arlt MF, Glover TW (2004). 
Chromosomal instability at common fragile sites in Seckel 
syndrome. Am J Hum  Genet, 75: 654-660. 
Chan KL, Palmai-Pallag T, Ying S, Hickson ID (2009). 
Replication stress induces sister-chromatid bridging at fragile 
site loci in mitosis. Nat Cell Biol, 11: 753-760. 
 
Chang NS (2002). A potential role of p53 and WOX1 in 
mitochondrial apoptosis. Int J Mol Med, 9: 19-24. Review. 
 
Chang NS, Doherty J, Ensign A (2003). JNK1 physically 
interacts with WW domain-containing oxidoreductase (WOX1) 
and inhibits WOX1-mediated apoptosis. J Biol Chem, 278: 
9195-9202. 
 
Chang NS, Pratt N, Heath J, Schultz L, Sleve D, et al. (2001). 
Hyaluronidase induction of a WWdomain-containing 
oxidoreductase that enhances tumor necrosis factor cytotoxicity. 
J Biol Chem, 276: 3361-3370. 
 
Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, 
et al. (1998). Frequent dysregulation of the c-maf proto-
oncogene at 16q23 by translocation to an Ig locus in multiple 
myeloma. Blood, 91: 4457-4463. 
 
Ciullo M, Debily MA, Rozier L, Autiero M, Billault A, Mayau 
V, El Marhomy S, Guardiola J, Bernheim A, Coullin P, Piatier-
Tonneau D, Debatisse M (2002). Initiation of the breakage-
fusion-bridge mechanism through common fragile site activation 
in human breast cancer cells: the model of PIP gene duplication 
from a break at FRA7I. Hum Mol Genet, 11: 2887-2894. 
 
Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M (1997). 
Expression of fragile sites triggers intrachromosomal 
Nazario Bosco 
Pag 88  
mammalian gene amplification and sets boundaries to early 
amplicons. Cell, 89: 215-225. 
 
Corbin S, Neilly ME, Espinosa R III, Davis EM, McKeithan 
TW, LeBeau MM (2002). Identification of unstable sequences 
within the common fragile site at 3p14.2: implications for the 
mechanism of deletions within fragile histidine triad 
gene/common fragile site at 3p14.2 in tumors. Cancer Res, 62: 
3477-3484. 
 
Curatolo A, Limongi ZM, Pelliccia F, Rocchi A (2007). 
Molecular characterization of the human common fragile site 
FRA1H. Genes Chromosomes Cancer, 46: 487-493. 
 
Debatisse M, Coquelle A, Toledo F, Buttin G (1998). Gene 
amplification mechanism: the role of fragile sites. Recent Results 
Cancer Res, 154: 216-226. 
 
Dekaban A (1965). Persisting clone with an abnormal 
chromosome in a woman prevously irradiated. J Nucl Med, 6: 
740-746. 
 
Dessen P, Knuutila S, Huret JL (2010). Chromosome. Atlas 
Cytogenet Oncol Haematol, July 2004. Updated 2010. 
 
Durkin SG, Arlt MF, Howlett NG, Glover TW (2006). Depletion 
of CHK1, but not CHK2, induces chromosomal instability and 
breaks at common fragile sites. Oncogene, 25: 4381-4389. 
 
Durkin SG and Glover TW (2007). Chromosome fagile sites. 
Annu Rev Genet, 41: 169-192. 
 
El Achkar E, Gerbault-Seureau M, Muleris M, Deutrillaux B, 
Debatisse M (2005). Premature condensation induces breaks at 
the interface of early and late replicating chromosome bands 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 89  
bearing common fragile sites. Proc Natl Acad Sci U.S.A., 102: 
18069-18074. 
 
Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover 
TW (2001). Translocation breakpoints in FHIT and FRA3B in 
both homologs of chromosome 3 in an esophageal 
adenocarcinoma. Genes Chromosomes Cancer, 30: 292-298. 
Feichtinger W and Schmid M (1989). Increased frequencies of 
sister chromatid exchanges at common fragile sites (1)(q42) and 
(19)(q13). Hum Genet, 83: 145-745. 
 
Freudenreich CH (2007). Chromosome fragility: molecular 
mechanisms and cellular consequences. Frontiers in Bioscience, 
12: 4911-4924. 
 
Gardiner K (1995). Human genome organization. Curr Opin  
Genet Dev, 5: 315-322. Review. 
 
Glover TW, Berger C, Coyle J, Echo B (1984). DNA 
polymerase a inhibition by aphidicolin induces gaps and breaks 
at common fragile sites in human chromosomes. Hum Genet, 
67: 136-142. 
 
Glover TW and Stein CK (1987). Induction of sister chromatid 
exchange at common fragile sites. Am J Hum Genet, 41: 882-
890. 
 
Glover TW and Stein CK (1988). Chromosome breakage and 
recombination at fragile sites. Am J Hum Genet, 43: 265-273. 
 
Glover TW (1998). Instability at chromosomal fragile sites. 
Recent Results Cancer Res, 154: 185-199. Review. 
 
Nazario Bosco 
Pag 90  
Glover TW, Arlt MF, Casper AM, Durkin SG (2005). 
Mechanism of common fragile site instability. Hum Mol Genet, 
14: 197-205. Review. 
 
Gu Y, Shen Y, Gibbs RA, Nelson DL (1996). Identification of 
FMR2, a novel gene associated with the FRAXE CCG repeat 
and CpG island. Nat Genet, 13: 109-113. 
 
Handt O, Sutherland GR, Richards RI (2000). Fragile sites and 
minisatellite repeat instability. Mol Genet Metab, 70: 99-105. 
Review. 
Hansen RS, Canfield TK, Lamb MM, Gartler SM, Laird CD 
(1993). Association of fragile X syndrome with delayed 
replication of the FMR1 gene. Cell, 73: 1403-1409. 
 
Harrison JC and Haber JE (2006). Surviving the breakup: the 
DNA damage checkpoint. Annu Rev Genet, 40: 209-235. 
 
Hecht F and Glover TW (1984). Cancer chromosome 
breakpoints and common fragile sites induced by aphidicolin. 
Cancer Genet Cytogenet, 13: 185-188. 
 
Hellman A, Rahat A, Scherer SW, Darvasi A, Tsui LC, Kerem 
B (2000). Replication delay along FRA7H, a common fragile 
site on human chromosome 7. Mol Cell Biol, 20: 4420-4427. 
 
Hellman A, Zlotorynski E, Scherer SW, Cheung J, Vincent JB, 
Smith DI, Trakhtenbrot L, Kerem B (2002). A role for common 
fragile site induction in amplification of human oncogenes. 
Cancer Cell, 1: 89-97. 
 
Hewett DR, Handt O, Hobson L, Mangeldorf M, Eyre HJ, et al. 
(1998). FRA10B structure reveals common elements in repeat 
expansion and chromosomal fragile sites genesis. Mol Cell, 1: 
773-781.  
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 91  
 
Hirsch B (1991). Sister chromatid exchanges are preferentially 
induced at expressed and nonexpressed common fragile sites. 
Hum Genet, 87: 302-306. 
 
Howlett NG, Taniguci T, Durkin SG, D’Andrea AD, Glover TW 
(2005). The Fanconi anemia pathway is required for the DNA 
replication stress response and for regulation of common fragile 
site stability. Hum Mol Genet, 14: 693-701. 
 
Hsu YY and Wang YH (2002). Human fragile site FRA16B 
DNA excludes nucleosomes in the presence of distamycin. J 
Biol Chem, 277: 17315-17319. 
 
Huebner K and Croce CM (2001). FRA3B and other common 
fragile sites: the weakest links. Nat Rev Cancer, 1: 214-221. 
 
Huebner K and Croce CM (2003). Cancer and the FRA3B/FHIT 
fragile locus: it’s a HIT. Br J Cancer, 88: 1501-1506. 
 
Ijdo JW, Wells RA, Baldini A, Reeders ST (1991). Improved 
telomere detection using a telomere repeat probe (TTAGGG)n 
generated by PCR. Nucleic Acid Research, 19: 4780. 
 
Jeppesen C and Nielsen PE (1989). Photofootprinting of drug-
binding sites on DANN using diazo- and azido-9-aminoacridine 
derivatives. Eur J Biochem, 182: 437-444. 
 
Jiang Y, Lucas I, Young DJ, Davis EM, Karrison T, Rest JS, Le 
Beau MM (2009). Common fragile sites are characterized by 
histone hypoacetylation. Hum Mol Genet, 18: 4501-4512. 
 
Keck CL, Zimonjic DB, Yuan BZ, Thorgeisson SS, Popescu NC 
(1999). Nonrandom breakpoints of unbalanced chromosome 
Nazario Bosco 
Pag 92  
translocations in human hepatocellular carcinoma cell lines. 
Cancer Genet Cytogenet, 111: 37-44. 
 
Kuo MT, Vyas RC, Jiang LX, Hittelman WN (1994). 
Chromosome breakage at a major fragile site associated with P-
glycoprotein gene amplification in multidrug-resistant CHO 
cells. Mol Cell Biol, 14: 5202-5211. 
 
Laird C, Jaffe E, Karpen G, Lamb M, Nelson R (1987). Fragile 
sites in human chromosomes as regions of late-replicating DNA. 
Trends Genet, 3: 274-281. 
Le Beau MM, Rassool FV, Neilly ME, Espinosa R, Glover TW, 
Smith DI, McKeithan TW (1998). Replication of a common 
fragile site, FRA3B, occurs late in S phase and is delayed further 
upon induction: implications for the mechanism of fragile site 
induction. Hum Mol Genet, 7: 755-761. 
 
Limongi MZ, Pelliccia F, Rocchi A (2003). Characterization of 
the human common fragile site FRA2G. Genomics, 81: 93-97. 
 
Limongi MZ, Curatolo A, Pelliccia F, Rocchi A (2005). Biallelic 
deletion and loss of expression analysis of genes at FRA2G 
common fragile site in tumor-derived cell lines. Cancer Genet 
Cytogenet, 181: 181-186. 
 
Lozzio CB and Lozzio BB (1957). Human chronic myelogenous 
leukemia cell line with positive Philadelphia chromosome. 
Blood, 45: 321-324. 
 
Magenis RE, Hecht F, Lovrien EW (1970). Heritable fragile site 
on chromosome 16: probable localization of haptoglobin locus 
in man. Science, 179: 85-87. 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 93  
Matsukuma S and Utakoji T (1978). Asimmetric decondensation 
of the L cell heterochromatin by Hoechst 33258. Exp Cell Res, 
113: 453-455. 
 
Mattei MG, Philip N, Pellissier MC, Piquet C, Mattei JF, Giraud 
F  (1987). A new rare fragile site on human chromosome 2. 
Cytogenet Cell Genet, 46: 658. 
 
McClintok B (1951). Chromosome organization and gene 
expression. In: Cold Spring Arbor Symp Quant Biol, 16: 13-47. 
 
Millikangas S, Himberg J, Böhling T, Nagy B, Hollmén J, 
Knuutila S (2006). DNA copy number amplification profiling of 
human neoplasms.. Oncogenomics, 25: 7324-7332. 
 
Mishmar D, Rahat A, Scherer SW, Nyakatura G, Hinzmann B, 
Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, 
Margalit H, Platzer M, Weiss A, Tsui LC, Rosenthal A, Kerem 
B (1998). Molecular characterization of a common fragile site 
(FRA7H) on human chromosome 7 by cloning the human 
simian virus 40 integration site. Proc Natl Acad Sci U.S.A., 95: 
8141-8146. 
 
Mishmar D, Mandel-Gutfroind Y, Margalit H, Rahat A, Kerem 
B (1999). Common fragile sites: G-band characteristics within 
an R-band. Am J Hum Genet, 64: 908-910. 
 
Morley BJ, Abbott CA, Wood WG  (1991). Regulation of 
human fetal and adult globin genes in mouse erythroleukemia 
cells. Blood, 78: 1355-1363. 
 
Mrasek K, Schoder C, Teichmann AC, Behr K, Franze B, 
Wilhelm K, Blaurock N, Claussen U, Liehr T and Weise A 
(2010). Global screening and extended nomenclature for 230 
Nazario Bosco 
Pag 94  
aphidicolin-inducible fragile sites, including 61 yet unreported 
ones. Int J Onc, 36:  929-940. 
 
Musio A, Montagna C, Mariani T, Tilenni M, Focarelli ML, et 
al. (2005). SMC1 involvement in fragile site expression. Hum 
Mol Genet, 14: 525-533. 
 
Naumann S, Reutzel D, Speiker M, Decker CK (2001). 
Complete karyotype characterization of the K562 cell line by 
combined application of G-banding, multiplex-fluorescence in 
situ hybridization, and comparative genomic hybridization. 
Leukemia Res, 25: 313-322. 
Nghiem P, Park PK, Kim YS, Vaziri C, Schreiber SL (2001). 
ATR inhibition selectively sensitizes G1 checkpoint-deficient 
cells to lethal premature chromatin condensation. Annu Rev 
Genet, 41: 169-192. 
 
Niimura Y and Gojobori T (2002). In silico chromosome 
staining: reconstruction of Giemsa bands from the whole human 
genome sequence. Proc Natl Acad Sci U.S.A., 99: 797-802. 
 
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, et al. 
(1996). The FHIT gene, spanning the chromosome 3p14.2 
fragile site and renal carcinoma-associated t(3;8) breakpoint, is 
abnormal in digestive tract cancers. Cell, 84: 587-597. 
 
O’Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin 
L, DePinho RA (2002). Telomere dysfunction provokes regional 
amplification and deletion in cancer genomes. Cancer Cell, 2: 
149-155. 
 
O’Keefe RT, Henderson SC, Spector DL (1992). Dynamic 
organization of DNA replication in mammalian cell nuclei: 
spatially and temporally defined replication of chromosome-
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 95  
specific alpha-satellite DNA sequences. J Cell Biol, 116: 1095-
1110. 
 
Paige AJW, Taylor KJ, Taylor C, Hillier SG, Farrington S, et al. 
(2001). WWOX: a candidate tumor suppressor gene involved in 
multiple tumor types. Proc Natl Acad Sci U.S.A., 98: 11417-
11422. 
 
Palakodeti A, Han Y, Jiang Y, Le Beau MM (2004). The role of 
late/slow replication of the FRA16D in common fragile site 
induction. Genes Chromosomes Cancer, 39: 71-76. 
 
Paradee W, Jayasankar V, Mullins C, Wilke C, Glover TW, 
Smith DI (1988). Molecular characterization of the 3p14.2 
constitutive fragile site. Am J Hum Genet, 55: A115. 
 
Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, Hoge 
A, Glover TW, Smith DI (1996). A 350-kb cosmid contig in 
3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma 
translocation breakpoint and 17 aphidicolin-induced FRA3B 
breakpoints. Genomics, 35: 87-93. 
 
Pekarsky Y, Garrison PN, Palamarchuk A, Zanesi N, Ageilan 
RI, et al. (2004). Fhit is a physiological target of the protein 
kinase Src. Proc Natl Acad Sci U.S.A., 101: 3775-3779. 
 
Pelletier R, Krasilnikova MM, Samadashwily GM, Lahue R, 
Mirkin SM (2003). Replication and expansion of trinucleotide 
repeats in yeast. Mol Cell Biol, 23: 1349-1357. 
 
Pelliccia F and Rocchi A (1986). DAPI-inducible common 
fragile sites. Cytogenet Cell Genet, 42: 174-176. 
 
Nazario Bosco 
Pag 96  
Pelliccia F and Rocchi A (1988). Synergistic effect of DAPI and 
thymidylate stress conditions on the induction of common 
fragile sites. Cytogenet Cell Genet, 48: 51-54. 
 
Pelliccia F, Curatolo A, Limongi ZM, Bosco N, Rocchi A 
(2007). Transcriptional profiling of genes at the human common 
fragile site FRA1H in tumor-derived cell lines. Cancer Genet 
Cytogenet, 178: 144-150. 
 
Pelliccia F, Bosco N, Curatolo A, Rocchi A (2008). Replication 
timing of two human  common fragile sites: FRA1H and 
FRA2G. Cytogenet Genome Res, 121: 196-200. 
 
Pelliccia F, Bosco N, Rocchi A (2010). Breakages at common 
fragile sites set boundaries of  amplified regions in two leukemia 
cell lines K562 - Molecular characterization of FRA2H and 
localization of a new CFS FRA2S. Cancer Letters, 299: 37-44. 
 
Popescu NC and DiPaolo JA (1989). Preferential sites for viral 
integration on mammalian genome. Cancer Genet Cytogenet, 
42: 157-171. 
 
Popovici C, Basset C, Bertucci F, Orsetti B, Adelaide J, et al. 
(2002). Reciprocal translocations in breast tumor cell lines: 
cloning of a t(3;20) that targets the FHIT gene. Genes 
Chromosomes Cancer, 35: 204-218. 
 
Portugal J and Waring MJ (1988). Assignment of DNA binding 
sites for 4’,6-diamidine-2-phenylindole and bisbenzimide 
(Hoechst 33258). A comparative footprinting study. Biochim 
Biophys Acta, 949: 158-168. 
 
Prantera G, Di Castro M, Cipriani L, Rocchi A (1981). 
Inhibition of human chromosome condensation induced by 
DAPI as related to cell cycle. Exp Cell Res, 135: 63-68. 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 97  
 
Ragland RL, Glynn MW, Arlt MF, Glover TW (2008). Stably 
transfected common fragile site sequences exhibit instability at 
ectopic sites. Genes Chromosomes Cancer, 47: 860-872. 
 
Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa 
RD, Le Beau MM (1991). Preferential integration of marker 
DNA into the chromosomal fragile site at 3p14: an approach to 
cloning fragile sites. Proc Natl Acad Sci U.S.A., 88: 6657-6661. 
 
Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, 
Smith DI, Gollin SM (2007). Relationship between FRA11F and 
11q13 gene amplification in oral cancer. Genes Chromosomes 
Cancer, 46: 143-154. 
 
Ruiz-Herrera A, Castresana J, Robinson TJ (2006). Is 
mammalian chromosomal evolution driven by regions of 
genome fragility? Genome Biol, 7: R115. 
 
Sadoni N, Langer S, Fauth C, Bernardi G, Cremer T, et al. 
(1999). Nuclear organization of mammalian genomes: polar 
chromosomes territories build up functionally distinct higher 
order compartments. J Cell Biol, 146: 1211-1226. 
 
Samadashwily GM, Raca G, Mirkin SM (1997). Trinucleotide 
repeats affect DNA replication in vivo. Nat Genet, 17: 298-304. 
 
Schwartz M, Zlotorynski E, Goldberg M, Ozeri E, Rahat A, 
Kerem B (2005). Homologous recombination and 
nonhomologous end-joining repair pathways regulate fragile site 
stability. Genes Dev, 19: 2715-2726. 
 
Schwartz M, Zlotorynski E, Kerem B (2006). The molecular 
basis of common and rare fragile sites. Cancer Lett, 232: 13-26. 
Review. 
Nazario Bosco 
Pag 98  
 
Selig S, Okumura K, Ward DC, Cedar H (1992). Delineation of 
DNA replication time zones by fluorescent in situ hybridization. 
EMBO J, 11: 1217-1225. 
 
Shi Y, Zou M, Farid NR, Paterson MC (2000). Association of 
Fhit (fragile histidine triad) a candidate tumor suppressor gene, 
with the ubiquitin-conjugating enzime hUBC9. Biochem, 352: 
443-448. 
 
Shuster MJ, Han L, Le Beau MM, Davis E, Sawicki M, Lese 
CM, Park NH, Colicelli J, Gollin S (2000). A consistent pattern 
of RINI rearrangements in oral squamous cell carcinoma cell 
lines supports a breakage-fusion-bridge cycle model for 11q13 
amplification. Genes Chromosomes Cancer, 28: 153-163. 
 
Sinclair PB, Harrison CJ, Jarosova M, Foroni L (2005). Analysis 
of balanced rearrangements of chromosome 6 in acute leukemia: 
clustered breakpoints in q22-q23 and possible involvement of c-
MYB in a new recurrent translocation, t(6;7)(q23;q32~36) . 
Haematologica, 90: 602-611. 
 
Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, et 
al. (1997). Replacement of Fhit in cancer cells suppresses 
tumorigenicity. Proc Natl Acad Sci U.S.A., 94: 13771-13776. 
 
Smit A (1999). Interspersed repeats and other mementos of 
transposable elements in mammalian genomes. Curr Opin Genet 
Dev, 6: 657-663. 
 
Smith ZE and Higgs DR (1999). The pattern of replication at a 
human telomeric region (16p13.3): its relationship to 
chromosome structure and gene expression. Hum Mol Genet, 8: 
1373-1386. 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 99  
Smith DI, Zhu Y, McAvoy S, Khun R  (2006). Common fragile 
sites, extremely large genes, neural development and cancer. 
Cancer Letters, 232: 48-57. 
 
Smith PP, Friedman C, Bryant EM, McDougall JK (2007). Viral 
integration and fragile sites in human papillomavirus-
immortalized human keratinocyte cell lines. Genes 
Chromosomes Cancer, 5: 150-157. 
 
Subramanian PS, Nelson DL, Chinault AC (1996). Large 
domains of apparent delayed replication timing associated with 
triplet repeat expansion at FRAXA and FRAXE. Am J Hum 
Genet, 59: 407-416. 
 
Sutherland GR and Hecht F (1985). Fragile sites on human 
chromosomes. In: Oxford Monographs on Medical Genetics, 
Oxford University Press, Oxford, UK. 
 
Sutherland GR and Richards RI (1995). The molecular basis of 
fragile sites in human chromosomes. Curr Opin Genet Dev, 5: 
323-327. 
 
Sutherland GR, Parslow MI, Baker E (1985). New classes of 
common fragile sites induced by 5-azacytidine and 
bromodeoxyuridine. Hum Genet, 69: 233-237. 
 
Sutherland GR (2003). Rare fragile sites. Cytogenet Gen Res, 
100: 77-84. 
 
Svetlova EY, Razin SV, Debatisse M (2001). Mammalian 
recombination hot spot in a DNA loop anchorage region: a 
model for the study of common fragile sites. J Cell Biochem 
Suppl, 36: 170-178. 
 
Nazario Bosco 
Pag 100  
Takebayashi SI, Manders EM, Kimura H, Taguchi H, Okumura 
K (2001). Mapping sites where replication initiates in 
mammalian cells using DNA fibers. Exp Cell Res, 271: 263-268. 
 
Takebayashi SI, Sugimura K, Saito T, Sato C, Fukushima Y, 
Taguchi H, Okumura K (2005). Regulation of replication at the 
R/G chromosomal band boundary and pericentromeric 
heterochromatin of mammalian cells. Exp Cell Res, 304: 162-
174. 
 
Taniguchi T and D’Andrea AD (2002). The Fanconi anemia 
protein, FANCE, promotes the nuclear accumulation of 
FANCC. Blood, 100: 2457-2462. 
 
The BAC Resource Consortium: integration of cytogenetic 
landmarks into the draft sequence of the human genome (2001). 
Nature, 409: 953-958. 
 
Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, 
et al. (2000). Human papillomavirus type 16 integrations in 
cervical tumors frequently occur in common fragile sites. 
Cancer Res, 60: 5916-5921. 
 
Toledo F, Coquelle A, Svetlova E, Debatisse M (2000). 
Enhanced flexibility and aphidicolin-induced DNA breaks near 
mammalian replication origins: implications for replicon 
mapping and chromosome fragility.  Nucl Acids Res, 28: 4805-
4813. 
 
Tsukasaki K, Miller CW, Greenspun E, Eshaghian S, Kawabata 
H, Fujimoto T, et al. (2001). Mutations in the mitotic check 
point gene, MAD1L1, in human cancers. Oncogene, 20: 3301-
3305. 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 101  
Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber 
ER, et al. (2009). Dicer-regulated microRNAs 222 and 339 
promote resistance of cancer cells to cytotoxic T-lymphocytes 
by down-regulation of ICAM-1. Proc Natl Acad Sci U.S.A., 106: 
10746-10751. 
 
Wang L, Paradee C, Mullins C, Shridhar S, Rosati R, Wilke 
CM, Glover TW, Smith DI (1997). Aphidicolin-induced FRA3B 
breakpoints cluster in two distinct regions. Genomics, 41: 485-
488. 
 
Wang L, Darling J, Zhang JS, Huang H, Liu W and Smith DI 
(1999). Allele-specific late replication and fragility of the most 
active common fragile site, FRA3B . Hum Mol Genet, 8: 431-
437. 
 
Widrow RJ, Hansen RS, Kawame H, Gartler SM, Laird CD 
(1998). Very late DNA replication in the human cell cycle. Proc 
Natl Acad Sci U.S.A., 95: 11246-11250. 
 
Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW 
(1996). FRA3B extends over a broad region and contains a 
spontaneous HPV16 integration site: direct evidence for the 
coincidence of viral integration sites and fragile sites. Hum Mol 
Genet, 5: 187-195.  
 
Woinarowski JM, Trevino AV, Rodriguez KA, Hardies SC, 
Benham CJ (2001). AT-rich islands in genomic DNA as a novel 
target for AT-specific DNA-reactive antitumor drugs. J Biol 
Chem, 276: 40555-40566. 
 
Yu S, Pritchard E, Kremer E, Lynch M, Nancarrow J, Baker E, 
Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland 
GR, Richard RI.  (1991). Fragile X genotype characterized by an 
unstable region of DNA.. Science, 252: 1179-1181. 
Nazario Bosco 
Pag 102  
 
Yu S, Mangelsdorf M, Hewett D, Hobson L,  Baker E et al. 
(1997). Human chromosomal fragile site FRA16B is an 
amplified AT-rich minisatellite repeat. Cell 88: 367-374. 
 
Yunis JJ and Soreng AL (1984). Constitutive fragile sites and 
cancer. Science, 226: 1199-1204. 
 
Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, et al. 
(2001). The tumor spectrum in Fhit-deficient mice. Proc Natl 
Acad Sci U.S.A., 98: 10250-10255. 
 
Zimonjic DB, Durkin ME, Keck-Waggoner CL, Park SW, 
Thorgeirsson SS, Popescu NC (2003). SMAD5 gene expression, 
rearrangements, copy number, and amplification at fragile site 
FRA5C in human hepatocellular carcinoma. Neoplasia, 5: 390-
396. 
 
Zlotorynski E, Rabat A, Skaug J, Ben-Porat N, Ozeri E, 
Hershberg R, Levi A, Scherer SW, Margalit H, Kerem B (2003). 
Molecular basis for expression of common and rare fragile sites. 
Mol Cell Biol, 23: 7143-7151. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dottorato di ricerca in Genetica e Biologia Molecolare 
 Pag. 103  
 
 
 
ACKNOWLEDGEMENTS 
 
 
 
 
Foremost, I would like to express my sincere gratitude to 
my advisor Prof. Franca Pelliccia. Her guidance helped me in all 
the time of research and writing of this thesis. I warmly thank 
Prof. Angela Rocchi for her constructive comments and 
immense knowledge. I owe my most sincere gratitude to Prof. 
Francesca Degrassi for her detailed and constructive comments. 
I could not have imagined having a better tutor for my Ph.D 
study. 
During this work I have collaborated with many 
colleagues for whom I have great regard, and I wish to extend 
my warmest thanks to all those who have helped me with my 
work. I would never forget the great time I spent with Silvia 
Baldari, Carmela Viscomi, Valentina Ubertini, Simona Graziano 
and Ilaria Passacantilli. Thanks girls! 
I am indebted to my many student and colleagues for 
providing a stimulating and fun environment in which to learn 
and grow. I am especially grateful to Eleonora Breno, Romina 
Burla and Antonella Friscini.   
Lastly, and most importantly, I wish to thank Angela 
Curatolo. The joy and enthusiasm she has for her research was 
contagious and motivational for me, even during tough times in 
the Ph.D. pursuit. To her I dedicate this thesis. 
Finally I have to thank my family for the constant love 
and support, for instilling in me confidence and a drive for 
pursuing my PhD, even if they never actually understood what I 
do in the laboratory. 
